Antonius Johannes Rabelink
Professor Internal Medicine, in particular nephrology
- Name
- Prof.dr. A.J. Rabelink
- Telephone
- +31 71 526 2148
- a.j.rabelink@lumc.nl
- ORCID iD
- 0000-0001-6780-5186
Ton (A.J.) Rabelink is professor of Internal Medicine, head of the division of Nephrology, head of the department of Internal Medicine and head of division 2. In addition, he is the figurehead of the route Regenerative Medicine for the Dutch Science Agenda, chair of the Dutch federation of nephrology, and board member of the Bontius and Möller Foundation
Ton (A.J.) Rabelink is professor of Internal Medicine, head of the division of Nephrology, head of the department of Internal Medicine and head of division 2. In addition, he is the figurehead of the route Regenerative Medicine for the Dutch Science Agenda, chair of the Dutch federation of nephrology, and board member of the Bontius and Möller Foundation.
Renal diseases
Currently, in his capacity as professor of Internal Medicine in particular renal diseases, he is the programme leader of 4 research programmes within the LUMC. These 4 programmes are related to the divisions part of his department, namely Nephrology, Endocrinology, Geriatrics and gerontology and Thrombosis and haemostasis.
Furthermore, professor Rabelink is (co-) chair of the profile area Vascular and Regenerative Medicine both at LUMC and University Leiden.
Academic career
Ton (A.J.) Rabelink, MD, PhD, is professor of Medicine at the Leiden University Medical Center. He received his MD PhD degree from Utrecht University. The title of his thesis in 1990 read: On the renal response to head-out water immersion. After completing his residency and fellowships in internal medicine and nephrology he joined the faculty of Utrecht Medical School in 1993. Through the Dutch Kidney Foundation he became a professor by special installment in 1998, after which in 2000 he was installed as professor by Utrecht University. Subsequently, he was appointed chairman of medicine in the University Hospital Utrecht from 1999 to 2004.
In 2004 he moved to Leiden University Medical Center and became head of the department of Nephrology and Transplantation and in 2010 chairman of Medicine again.
His main research interest has been in the area of vascular biology and its implications for renal function, and in regenerative therapies for kidney disease and diabetes.
Follw A.J. Rabelink
Professor Internal Medicine, in particular nephrology
- Faculteit Geneeskunde
- Divisie 2
- Interne Geneeskunde
- Nierziekten
- Leeuwen, J.R. van; Penne, E.L.; Rabelink, T.; Knevel, R. & Teng, Y.K.O. (2024), Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records, Computers in Biology and Medicine 168.
- Yuan, L.S.; Verhoeven, A.; Blomberg, N.; Eyk, H.J. van; Bizino, M.B.; Rensen, P.C.N.; Jazet, I.M.; Lamb, H.J.; Rabelink, T.J.; Giera, M. & Berg, B.M. van den (2024), Ethnic disparities in lipid metabolism and clinical outcomes between Dutch South Asians and Dutch White Caucasians with type 2 diabetes mellitus, Metabolites 14(1).
- Gaykema, L.H.; Nieuwland, R.Y. van; Dekkers, M.C.; Essen, M.F. van; Heidt, S.; Zaldumbide, A.; Berg, C.W. van den; Rabelink, T.J. & Kooten, C. van (2023), Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids, Frontiers in Immunology 13.
- Gaykema, L.H.; Nieuwland, R.Y. van; Lievers, E.; Moerkerk, W.B.J.; Klerk, J.A. de; Dumas, S.J.; Kers, J.; Zaldumbide, A.; Berg, C.W. van den & Rabelink, T.J. (2023), T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids, Stem Cells Translational Medicine.
- Wiersma, L.E.; Avramut, M.C.; Koster, A.J.; Berg, C.W. van den & Rabelink, T.J. (2023), Ultrastructural characterization of maturing iPSC-derived nephron structures upon transplantation, Microscopy Research & Technique.
- Yuan, L.S.; Han, J.H.; Velden, A.I.M.V.; Vink, H.; Mutsert, R. de; Rosendaal, F.R.; Vlieg, A.V.; Li-Gao, R.; Rabelink, T.J. & Berg, B.M. van den (2023), Sex-specific association between microvascular health and coagulation parameters: the Netherlands Epidemiology of Obesity study, Journal of Thrombosis and Haemostasis 21(9): 2585-2595.
- Leeuwen, J.R. van; Hafemann, S.; Boog, P. van der; Woude, D. van der; Rabelink, T. & Teng, Y.K.O. (2023), The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis, Clinical Kidney Journal 16(12): 2754-2756.
- Arends, E.J.; Meziyerh, S.; Moes, D.J.A.R.; Kamerling, S.W.A.; Kooy, S. van der; Ogando, N.S.; Snijder, E.J.; Hemert, M. van; Visser, L.G.; Feltkamp, M.C.W.; Claas, E.C.J.; Rabelink, T.J.; Kooten, C. van; Vries, A.P.J. de & Teng, Y.K.O. (2023), Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients, Kidney International Reports 8(12): 2654-2664.
- Rietjens, R.G.J. & Rabelink, T.J. (2023), Unveiling the role of Mfsd2a and LPC-DHA in kidney repair, Journal of Lipid Research 64(9).
- Leeuwen, J.R.V.; Rabelink, T.J. & Teng, Y.K.O. (2023), Response to "Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation".
- Leeuwen, J.R. van; Popov, T.; Obergfell, A.; Rabelink, T.J. & Teng, Y.K.O. (2023), Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANC A-Associated Vasculitis, Biologics: Targets and Therapy 17: 11-14.
- Rietjens, R.G.J.; Wang, G.Q.; Velden, A.I.M. van der; Koudijs, A.; Avramut, M.C.; Kooijman, S.; Rensen, P.C.N.; Vlag, J. van der; Rabelink, T.J.; Heijs, B. & Berg, B.M. van den (2023), Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes, Scientific Reports 13(1).
- Gaykema, L.H.; Nieuwland, R.Y. van; Dekkers, M.C.; Essen, M.F. van; Heidt, S.; Zaldumbide, A.; Berg, C.W. van den; Rabelink, T.J. & Kooten, C. van (2023), Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids, Frontiers in Immunology 13.
- Garsen, M.; Buijsers, B.; Sol, M.; Gockeln, L.; Sonneveld, R.; Kuppevelt, T.H. van; Graaf, M. de; Born, J. van den; Kamps, J.A.A.M.; Raalte, D.H.V.; Meer, R.W. van der; Lamb, H.J.; Hillebrands, J.L.; Rabelink, T.J.; Maciej-Hulme, M.L.; Krenning, G.; Nijenhuis, T. & Vlag, J. van der (2023), Peroxisome proliferator-activated receptory agonist mediated inhibition of heparanase expression reduces proteinuria, EBioMedicine 90.
- Gabbin, B.; Meraviglia, V.; Angenent, M.L.; Ward-van Oostwaard, D.; Sol, W.; Mummery, C.L.; Rabelink, T.J.; Meer, B.J. van; Berg, C.W. van den & Bellin, M. (2023), Heart and kidney organoids maintain organ-specific function in a microfluidic system, Materials Today Bio 23.
- Haan, M.J.A. de & Rabelink, T.J. (2023), Cryopreservation breaks the organ transplant time barrier, Nature Reviews Nephrology 19(10): 623-624.
- Koning, M.; Lievers, E.; Jaffredo, T.; Berg, C.W. van den & Rabelink, T.J. (2023), Efficient Vascularization of Kidney Organoids through Intracelomic Transplantation in Chicken Embryos, Journal of Visualized Experiments.
- Jacobs, M.E.; Vries, D.K. de; Engelse, M.A.; Dumas, S.J. & Rabelink, T.J. (2023), Endothelial to mesenchymal transition in kidney fibrosis, Nephrology Dialysis Transplantation.
- Buijsers, B.; Maciej-Hulme, M.; Jacobs, M.; Bebber, M.B.V.; Graaf, M. de; Salmenov, R.; Parr, N.; Rabelink, T.J.; Nijenhuis, T. & Vlag, J. van der (2023), Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis, Frontiers in Molecular Biosciences 10.
- Maciej-Hulme, M.L.; Gemst, J.J. van; Sanderson, P.; Rops, A.L.W.M.M.; Berden, J.H.; Smeets, B.; Amster, I.J.; Rabelink, T.J. & Vlag, J. van der (2023), Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis, Frontiers in Molecular Biosciences 10.
- Wiersma, L.E.; Avramut, M.C.; Koster, A.J.; Berg, C.W. van den & Rabelink, T.J. (2023), Ultrastructural characterization of maturing iPSC-derived nephron structures upon transplantation, Microscopy Research & Technique 87(3).
- Rabelink, T.J. (2022), STEM CELL DERIVED KIDNEY TISSUE, AND ITS CHALLENGES FOR CLINICAL TRANSLATION, Tissue Engineering Part A 28: S650-S650.
- Wiersma, L.; Berg, C. van den; Lievers, E. & Rabelink, T. (2022), SCALABILITY OF HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED KIDNEY TISSUE ORGANOIDS, A STEP TOWARDS CLINICAL APPLICATION, Tissue Engineering Part A 28: S299-S300.
- Rietjens, R.; Wang, G.; Sol, W.; Heijs, B.; Berg, B. van den & Rabelink, T. (2022), LIPID CHANGES AS EARLY INDICATOR FOR DIABETES INDUCED RENAL PATHOLOGY, Nephrology Dialysis Transplantation 37: I889-I890.
- Arends, E.J.; Zlei, M.; Tipton, C.M.; Cotic, J.; Osmani, Z.; Bie, F. de; Kamerling, S.; Maurik, A. van; Dimelow, R.; Gregan, Y.I.; Fox, N.L.; Rabelink, T.; Roth, D.; Sanz, I.; Dongen, J.J.M. van; Kooten, C. van & Teng, Y.K.O. (2022), BELIMUMAB DISRUPTS MEMORY B-CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, Annals of the Rheumatic Diseases 81: 324-325.
- Wang, G.Q.; Heijs, B.; Kostidis, S.; Rietjens, R.G.J.; Koning, M.; Yuan, L.S.; Tiemeier, G.L.; Mahfouz, A.; Dumas, S.J.; Giera, M.; Kers, J.; Lopes, S.M.C.D.; Berg, C.W.V.; Berg, B.M.V. & Rabelink, T.J. (2022), Spatial dynamic metabolomics identifies metabolic cell fate trajectories in human kidney differentiation, Cell Stem Cell 29(11): 1580-+.
- Khalil, R.; Boels, M.G.S.; Group, P.; Berg, B.M. van den; Bruijn, J.A.; Rabelink, T.J.; Hogendoorn, P.C.W. & Baelde, H.J. (2022), Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier, Molecular Genetics and Genomics 297.
- Zhao, Q.; Nooren, S.J.L.; Zijlstra, L.E.; Westenberg, J.J.M.; Kroft, L.J.M.; Jukema, J.W.; Berkhout-Byrne, N.C.; Rabelink, T.J.; Zonneveld, A.J. van; Buren, M. van; Mooijaart, S.P. & Bijkerk, R. (2022), Circulating miRNAs and vascular injury markers associate with cardiovascular function in older patients reaching end-stage kidney disease, Non-Coding RNA 8(1).
- Wind, M.; Akker-van Marle, M.E. van den; Ballieux, B.E.P.B.; Cobbaert, C.M.; Rabelink, T.J.; Lith, J.M.M. van; Teng, Y.K.O. & Sueters, M. (2022), Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia , BMC Pregnancy and Childbirth 22(1).
- Leeuwen, J.R. van; Bredewold, O.W.; Dam, L.S. van; Werkman, S.L.; Jonker, J.T.; Geelhoed, M.; Langeveld, A.P.M.; Remmelts, H.H.F.; Broecke, M.M. van den; Ray, A.; Rabelink, T.J. & Teng, Y.K.O. (2022), Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Wang, G.Q.; Heijs, B.; Kostidis, S.; Mahfouz, A.; Rietjens, R.G.J.; Bijkerk, R.; Koudijs, A.; Pluijm, L.A.K. van der; Berg, C.W. van den; Dumas, S.J.; Carmeliet, P.; Giera, M.; Berg, B.M. van den & Rabelink, T.J. (2022), Analyzing cell-type-specific dynamics of metabolism in kidney repair, Nature Metabolism 4.
- Dirikgil, E.; Brons, K.; Duindam, M.; Groeneveld, G.H.; Geelhoed, J.J.M.; Heringhaus, C.; Boog, P.J.M. van der; Rabelink, T.J.; Bos, W.J.W.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2022), COVID-box experiences of patients and health care professionals (COVID-box project), JMIR Formative Research 6(7).
- Arends, E.J.; Zlei, M.; Tipton, C.M.; Osmani, Z.; Bie, F. de; Kamerling, S.W.A.; Rabelink, T.; Sanz, I.; Dongen, J.J.M. van; Kooten, C. van & Teng, Y.K.O. (2022), BELIMUMAB DISRUPTS MEMORY B CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, Nephrology Dialysis Transplantation 37: I170-I170.
- Arends, E.J.; Zlei, M.; Tipton, C.M.; Cotic, J.; Osmani, Z.; Bie, F.J. de; Kamerling, S.W.A.; Maurik, A. van; Dimelow, R.; Gregan, Y.I.; Fox, N.L.; Rabelink, T.J.; Roth, D.A.; Sanz, I.; Dongen, J.J.M. van; Kooten, C. van & Teng, O. (2022), Belimumab Disrupts Memory B-Cell Trafficking in Patients with Systemic Lupus Erythematosus, Arthritis & Rheumatology 74: 3292-3293.
- Winkler, T.W.; Rasheed, H.; Teumer, A.; Gorski, M.; Rowan, B.X.; Stanzick, K.J.; Thomas, L.F.; Tin, A.; Hoppmann, A.; Chu, A.Y.; Tayo, B.; Thio, C.H.L.; Cusi, D.; Chai, J.F.; Sieber, K.B.; Horn, K.; Li, M.; Scholz, M.; Cocca, M.; Wuttke, M.; Most, P.J. van der; Yang, Q.; Ghasemi, S.; Nutile, T.; Li, Y.; Pontali, G.; Gunther, F.; Dehghan, A.; Correa, A.; Parsa, A.; Feresin, A.; Vries, A.P.J. de; Zonderman, A.B.; Smith, A.V.; Oldehinkel, A.J.; Grandi, A. de; Rosenkranz, A.R.; Franke, A.; Teren, A.; Metspalu, A.; Hicks, A.A.; Morris, A.P.; Tonjes, A.; Morgan, A.; Podgornaia, A.I.; Peters, A.; Korner, A.; Mahajan, A.; Campbell, A.; Freedman, B.I.; Spedicati, B.; Ponte, B.; Schottker, B.; Brumpton, B.; Banas, B.; Kramer, B.K.; Jung, B.; Asvold, B.O.; Smith, B.H.; Ning, B.; Penninx, B.W.J.H.; Vanderwerff, B.R.; Psaty, B.M.; Kammerer, C.M.; Langefeld, C.D.; Hayward, C.; Spracklen, C.N.; Robinson-Cohen, C.; Hartman, C.A.; Lindgren, C.M.; Wang, C.L.; Sabanayagam, C.; Heng, C.K.; Lanzani, C.; Khor, C.C.; Cheng, C.Y.; Fuchsberger, C.; Gieger, C.; Shaffer, C.M.; Schulz, C.A.; Willer, C.J.; Chasman, D.I.; Gudbjartsson, D.F.; Ruggiero, D.; Toniolo, D.; Czamara, D.; Porteous, D.J.; Waterworth, D.M.; Mascalzoni, D.; Mook-Kanamori, D.O.; Reilly, D.F.; Daw, E.W.; Hofer, E.; Boerwinkle, E.; Salvi, E.; Bottinger, E.P.; Tai, E.S.; Catamo, E.; Rizzi, F.; Guo, F.; Rivadeneira, F.; Guilianini, F.; Sveinbjornsson, G.; Ehret, G.; Waeber, G.; Biino, G.; Girotto, G.; Pistis, G.; Nadkarni, G.N.; Delgado, G.E.; Montgomery, G.W.; Snieder, H.; Campbell, H.; White, H.D.; Gao, H.; Stringham, H.M.; Schmidt, H.; Li, H.T.; Brenner, H.; Holm, H.; Kirsten, H.; Kramer, H.; Rudan, I.; Nolte, I.M.; Tzoulaki, I.; Olafsson, I.; Martins, J.; Cook, J.P.; Wilson, J.F.; Halbritter, J.; Felix, J.F.; Divers, J.; Kooner, J.S.; Lee, J.J.M.; O'Connell, J.; Rotter, J.I.; Liu, J.J.; Xu, J.; Thiery, J.; Arnlov, J.; Kuusisto, J.; Jakobsdottir, J.; Tremblay, J.; Chambers, J.C.; Whitfield, J.B.; Gaziano, J.M.; Marten, J.; Coresh, J.; Jonas, J.B.; Mychaleckyj, J.C.; Christensen, K.; Eckardt, K.U.; Mohlke, K.L.; Endlich, K.; Dittrich, K.; Ryan, K.A.; Rice, K.M.; Taylor, K.D.; Ho, K.; Nikus, K.; Matsuda, K.; Strauch, K.; Miliku, K.; Hveem, K.; Lind, L.; Wallentin, L.; Yerges-Armstrong, L.M.; Raffield, L.M.; Phillips, L.S.; Launer, L.J.; Lyytikainen, L.P.; Lange, L.A.; Citterio, L.; Klaric, L.; Ikram, M.A.; Ising, M.; Kleber, M.E.; Francescatto, M.; Concas, M.P.; Ciullo, M.; Piratsu, M.; Orho-Melander, M.; Laakso, M.; Loeffler, M.; Perola, M.; Borst, M.H. de; Gogele, M.; Bianca, M. la; Lukas, M.A.; Feitosa, M.F.; Biggs, M.L.; Wojczynski, M.K.; Kavousi, M.; Kanai, M.; Akiyama, M.; Yasuda, M.; Nauck, M.; Waldenberger, M.; Chee, M.L.; Chee, M.L.; Boehnke, M.; Preuss, M.H.; Stumvoll, M.; Province, M.A.; Evans, M.K.; O'Donoghue, M.L.; Kubo, M.; Kahonen, M.; Kastarinen, M.; Nalls, M.A.; Kuokkanen, M.; Ghanbari, M.; Bochud, M.; Josyula, N.S.; Martin, N.G.; Tan, N.Y.Q.; Palmer, N.D.; Pirastu, N.; Schupf, N.; Verweij, N.; Hutri-Kahonen, N.; Mononen, N.; Bansal, N.; Devuyst, O.; Melander, O.; Raitakari, O.T.; Polasek, O.; Manunta, P.; Gasparini, P.; Mishra, P.P.; Sulem, P.; Magnusson, P.K.E.; Elliott, P.; Ridker, P.M.; Hamet, P.; Svensson, P.O.; Joshi, P.K.; Kovacs, P.; Pramstaller, P.P.; Rossing, P.; Vollenweider, P.; Harst, P. van der; Dorajoo, R.; Sim, R.Z.H.; Burkhardt, R.; Tao, R.; Noordam, R.; Magi, R.; Schmidt, R.; Mutsert, R. de; Rueedi, R.; Dam, R.M. van; Carroll, R.J.; Gansevoort, R.T.; Loos, R.J.F.; Felicita, S.C.; Sedaghat, S.; Padmanabhan, S.; Freitag-Wolf, S.; Pendergrass, S.A.; Graham, S.E.; Gordon, S.D.; Hwang, S.J.; Kerr, S.M.; Vaccargiu, S.; Patil, S.B.; Hallan, S.; Bakker, S.J.L.; Lim, S.C.; Lucae, S.; Vogelezang, S.; Bergmann, S.; Corre, T.; Ahluwalia, T.S.; Lehtimaki, T.; Boutin, T.S.; Meitinger, T.; Wong, T.Y.; Bergler, T.; Rabelink, T.J.; Esko, T.; Haller, T.; Thorsteinsdottir, U.; Volker, U.; Foo, V.H.X.; Salomaa, V. & Vitart, (2022), Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals, Communications Biology 5(1).
- Wiersma, L.E.; Avramut, M.C.; Lievers, E.; Rabelink, T.J. & Berg, C.W. van den (2022), Large-scale engineering of hiPSC-derived nephron sheets and cryopreservation of their progenitors, Stem Cell Research and Therapy 13(1).
- Schaik, M. van; Arends, E.J.; Soonawala, D.; Ommen, E. van; Leeuw, K. de; Limper, M.; Paassen, P. van; Huizinga, T.W.J.; Toes, R.E.M.; Kooten, C. van; Rotmans, J.I.; Rabelink, T.J. & Teng, Y.K.O. (2022), Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: , Trials 23(1).
- Wind, M.; Akker-van Marle, M.E. van den; Ballieux, B.E.P.B.; Cobbaert, C.M.; Rabelink, T.J.; Lith, J.M.M. van; Teng, Y.K.O. & Sueters, M. (2022), Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study, BMC Pregnancy and Childbirth 22(1).
- Velden, A.I.M. van der; Berg, B.M. van den; Born, B.J. van den; Galenkamp, H.; Ijpelaar, D.H.T. & Rabelink, T.J. (2022), Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes, BMJ Open Diabetes Research and Care 10(6).
- Dirikgil, E.; Leeuwen, J.R. van; Bredewold, O.W.; Ray, A.; Jonker, J.T.; Soonawala, D.; Remmelts, H.H.F.; Dam, B. van; Bos, W.J.; Kooten, C. van; Rotmans, J.; Rabelink, T. & Teng, Y.K.O. (2022), ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial), BMJ Open 12(9).
- Yuan, L.S.; Cheng, S.Z.; Sol, W.M.P.J.; Velden, A.I.M. van der; Vink, H.; Rabelink, T.J. & Berg, B.M. van den (2022), Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit, ERJ Open Research 8(2).
- Dirikgil, E.; Tas, S.W.; Verburgh, C.A.; Soonawala, D.; Hak, A.E.; Remmelts, H.H.F.; IJpelaar, D.; Laverman, G.D.; Rutgers, A.; Laar, J.M. van; Moens, H.J.B.; Verhoeven, P.M.J.; Rabelink, T.J.; Bos, W.J.W.; Teng, Y.K.O. & Autoimmune Research Collaboration Hub (ARCH) study group (2022), Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients, Rheumatology Advances in Practice 6(2).
- Teng, Y.K.O. & Rabelink, T.J.J. (2022), Will New Treatment Options for Lupus Nephritis Be Affordable?, Clinical Journal of the American Society of Nephrology 17(3): 340-341.
- Koning, M.; Dumas, S.J.; Avramut, M.C.; Koning, R.I.; Meta, E.; Lievers, E.; Wiersma, L.E.; Borri, M.; Liang, X.; Xie, L.; Liu, P.; Chen, F.; Lin, L.; Luo, Y.L.; Mulder, J.; Spijker, H.S.; Jaffredo, T.; Berg, B.M. van den; Carmeliet, P.; Berg, C.W. van den & Rabelink, T.J. (2022), Vasculogenesis in kidney organoids upon transplantation, npj Regenerative Medicine 7(1).
- Gabbin, B.; Meraviglia, V.; Mummery, C.L.; Rabelink, T.J.; Meer, B.J. van; Berg, C.W. van den & Bellin, M. (2022), Toward Human Models of Cardiorenal Syndrome in vitro, Frontiers in Cardiovascular Medicine 9.
- Loeven, M.A.; Maciej-Hulme, M.L.; Yanginlar, C.; Hubers, M.C.; Kellenbach, E.; Graaf, M. de; Kuppevelt, T.H. van; Wetzels, J.; Rabelink, T.J.; Smith, R.J.H. & Vlag, J. van der (2021), Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies, Frontiers in Immunology 12.
- Wind, M.; Gaasbeek, A.G.A.; Oosten, L.E.M.; Rabelink, T.J.; Lith, J.M.M. van; Sueters, M. & Teng, Y.K.O. (2021), Therapeutic plasma exchange in pregnancy: a literature review, European Journal of Obstetrics and Gynecology and Reproductive Biology 260.
- Gemst, J.J. van; Passmann, N.J.H.G.; Rops, A.L.W.M.M.; Kuppevelt, T.H. van; Berden, J.H.; Loeven, M.A.; Rabelink, T.J.; Smeets, B. & Vlag, J. van der (2021), Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis, PLoS ONE 16(12).
- Geuens, T.; Ruiter, F.A.A.; Schumacher, A.; Morgan, F.L.C.; Rademakers, T.; Wiersma, L.E.; Berg, C.W. van den; Rabelink, T.J.; Baker, M.B. & LaPointe, V.L.S. (2021), Thiol-ene cross-linked alginate hydrogel encapsulation modulates the extracellular matrix of kidney organoids by reducing abnormal type 1a1 collagen deposition, Biomaterials 275.
- Dirikgil, E.; Jonker, J.T.; Tas, S.W.; Verburgh, C.A.; Soonawala, D.; Hak, A.E.; Remmelts, H.H.F.; IJpelaar, D.; Laverman, G.D.; Rutgers, A.; Laar, J.M. van; Moen, H.J.B.; Verhoeven, P.M.J.; Rabelink, T.J.; Bos, W.J.W.; Teng, Y.K.O. & Arthritis Res Collaboration Hub AR (2021), Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Netherlands, Kidney International Reports 6(10): 2671-2678.
- Wind, M.; Gaasbeek, A.G.A.; Oosten, L.E.M.; Rabelink, T.J.; Lith, J.M.M. van; Sueters, M. & Teng, Y.K.O. (2021), Therapeutic plasma exchange in pregnancy: a literature review, European Journal of Obstetrics and Gynecology and Reproductive Biology 260: 29-36.
- Wind, M.; Hendriks, M.; Brussel, B.T.J. van; Eikenboom, J.; Allaart, C.F.; Lamb, H.J.; Siebelink, H.M.J.; Ninaber, M.K.; Geloven, N. van; Lith, J.M.M. van; Huizinga, T.W.J.; Rabelink, T.J.; Sueters, M. & Teng, Y.K.O. (2021), Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome, Lupus Science & Medicine 8(1).
- Leenders, F.; Groen, N.; Graaf, N. de; Engelse, M.A.; Rabelink, T.J.; Koning, E.J.P. de & Carlotti, F. (2021), Oxidative stress leads to beta-cell dysfunction through loss of beta-cell identity, Frontiers in Immunology 12.
- Witjas, F.; Wang, G.; Graaf, A. de; Kostidis, S.; Avramut, C.; Haan, M. de; Alwayn, I.; Kers, J.; Kooten, C. van; Heijs, B.; Engelse, M. & Rabelink, T. (2021), METABOLISM-REGULATED SUB-NORMOTHERMIC CULTURE SYSTEM OF HUMAN KIDNEYS RETAINS EX VIVO VIABILITY FOR 4 DAYS, Transplant International 34: 64-64.
- Kraaij, T.; Arends, E.J.; Dam, L.S. van; Kamerling, S.W.A.; Daele, P.L.A. van; Bredewold, O.W.; Ray, A.; Bakker, J.A.; Scherer, H.U.; Huizinga, T.J.W.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2021), Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus, Nephrology Dialysis Transplantation 36(8): 1474-1483.
- Florijn, B.W.; Duijs, J.M.G.J.; Klaver, M.; Kuipers, E.N.; Kooijman, S.; Prins, J.; Zhang, H.Y.; Sips, H.C.M.; Stam, W.; Hanegraaf, M.; Limpens, R.W.A.L.; Nieuwland, R.; Rijn, B.B. van; Rabelink, T.J.; Rensen, P.C.N.; Heijer, M. den; Bijkerk, R. & Zonneveld, A.J. van (2021), Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452, European Journal of Endocrinology 185(4): 539-552.
- Reinders, M.E.J.; Groeneweg, K.E.; Hendriks, S.H.; Bank, J.R.; Dreyer, G.J.; Vries, A.P.J. de; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Meij, P.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Roelen, D.L.; Kooten, C. van; Kers, J.; Heidt, S.; Rabelink, T.J. & Fijter, J.W. de (2021), Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal, American Journal of Transplantation 21(9).
- Arends, E.J.; Zlei, M.; Tipton, C.M.; Osmani, Z.; Kamerling, S.W.A.; Rabelink, T.; Sanz, I.; Dongen, J.J.M. van; Kooten, C. van & Teng, Y.K.O. (2021), BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS, Nephrology Dialysis Transplantation 36.
- Arends, E.J.; Zlei, M.; Tipton, C.M.; Osmani, Z.; Kamerling, S.; Rabelink, T.; Sanz, I.; Dongen, J.J.M. van; Kooten, C. van & Teng, Y.K.O. (2021), BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE, Annals of the Rheumatic Diseases 80: 585-585.
- Galaris, G.; Montagne, K.; Thalgott, J.H.; Goujon, G.J.P.E.; Driesche, S. van den; Martin, S.; Mager, H.J.J.; Mummery, C.L.; Rabelink, T.J. & Lebrin, F. (2021), Thresholds of ENDOGLIN expression in endothelial cells explains vascular etiology in Hereditary Hemorrhagic Telangiectasia type 1, International Journal of Molecular Sciences 22(16).
- Dam, L.S. van; Dirikgil, E.; Bredewold, E.W.; Ray, A.; Bakker, J.A.; Kooten, C. van; Rabelink, T.J. & Teng, Y.K.O. (2021), PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab, Nephrology Dialysis Transplantation 36(8): 1408-1417.
- Dirikgil, E.; Roos, R.; Groeneveld, G.H.; Heringhaus, C.; Silven, A.V.; Petrus, A.H.J.; Villalobos-Quesada, M.; Tsonaka, R.; Boog, P.J.M.V.; Rabelink, T.J.; Bos, W.J.W.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2021), Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project.
- Apelt, K.; Bijkerk, R.; Lebrin, F. & Rabelink, T.J. (2021), Imaging the renal microcirculation in cell therapy, Cells 10(5).
- Teng, Y.K.O.; Dam, L. van; Oskam, J.; Kamerling, S.W.A.; Arends, E.J.; Bredewold, E.; Dongen, J.J.M. van; Rabelink, T.J. & Kooten, C. van (2021), HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS, Nephrology Dialysis Transplantation 36.
- Velden, A.I.M. van der; Berg, B.M. van den; Mutsert, R. de; Vlag, J. van der; Jukema, J.W.; Rosendaal, F.R.; Rabelink, T.J. & Vink, H. (2021), Microvascular differences in individuals with obesity at risk of developing cardiovascular disease, Obesity 29(9).
- Schroijen, M.A.; Mutsert, R. de; Dekker, F.W.; Vries, A.P.J. de; Koning, E.J.P. de; Rabelink, T.J.; Rosendaal, F.R. & Dekkers, O.M. (2021), The association of glucose metabolism and kidney function in middle-aged adults, CLINICAL KIDNEY JOURNAL 14(11): 2383-2390.
- Zhang, H.Y.; Vreeken, D.; Leuning, D.G.; Bruikman, C.S.; Junaid, A.; Stam, W.; Bruin, R.G. de; Sol, W.M.P.J.; Rabelink, T.J.; Berg, B.M. van den; Zonneveld, A.J. van & Gils, J.M. van (2021), Netrin-4 expression by human endothelial cells inhibits endothelial inflammation and senescence, International Journal of Biochemistry and Cell Biology 134.
- Dumas, S.J.; Meta, E.; Borri, M.; Luo, Y.L.; Li, X.R.; Rabelink, T.J. & Carmeliet, P. (2021), Phenotypic diversity and metabolic specialization of renal endothelial cells, Nature Reviews Nephrology 17(7): 441-464.
- Haan, M.J.A. de; Witjas, F.M.R.; Engelse, M.A. & Rabelink, T.J. (2021), Have we hit a wall with whole kidney decellularization and recellularization: a review, CURRENT OPINION IN BIOMEDICAL ENGINEERING 20.
- Timal, R.J.; Gucht, V. de; Rotmans, J.I.; Hensen, L.C.R.; Buiten, M.S.; Bie, M.K. de; Putter, H.; Schalij, M.J.; Rabelink, T.J. & Jukema, J.W. (2021), The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients, Quality of Life Research 30(6): 1605-1617.
- Groen, N.; Leenders, F.; Mahfouz, A.; Munoz-Garcia, A.; Muraro, M.J.; Graaf, N. de; Rabelink, T.J.; Hoeben, R.; Oudenaarden, A. van; Zaldumbide, A.; Reinders, M.J.T.; Koning, E.J.P.D. & Carlotti, F. (2021), Single-cell transcriptomics links loss of human pancreatic beta-cell identity to ER stress, Cells 10(12).
- Timal, R.J.; Kooiman, J.; Sijpkens, Y.W.J.; Vries, J.P.P.M. de; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Buren, M. van; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Jukema, J.W.; Rabelink, T.J. & Huisman, M.V. (2020), Effect of no prehydration vs sodium bicarbonate prehydration prior to contrast-enhanced computed tomography in the prevention of postcontrast acute kidney injury in adults with chronic kidney disease the Kompas randomized clinical trial, JAMA Internal Medicine 180(4): 533-541.
- Wang, G.Q.; Tiemeier, G.L.; Berg, B.M. van den & Rabelink, T.J. (2020), Endothelial glycocalyx hyaluronan regulation and role in prevention of diabetic complications, The American Journal of Pathology 190(4): 781-790.
- Berg, C.W. van den; Koudijs, A.; Ritsma, L. & Rabelink, T.J. (2020), In vivo assessment of size-selective glomerular sieving in transplanted human induced pluripotent stem cell-derived kidney organoids, Journal of the American Society of Nephrology 31(5): 921-929.
- Bruin, R.G. de; Vogel, G.; Prins, J.; Duijs, J.M.J.G.; Bijkerk, R.; Zande, H.J.P. van der; Gils, J.M. van; Boer, H.C. de; Rabelink, T.J.; Zonneveld, A.J. van; Veer, E.P. van der & Richard, S. (2020), Targeting the RNA-binding protein QKI in myeloid cells ameliorates macrophage-induced renal interstitial fibrosis, Epigenomes 4(1).
- Zonneveld, A.J. van; Au, Y.W.; Stam, W.; Gelderen, S. van; Rotmans, J.I.; Deen, P.M.T.; Rabelink, T.J. & Bijkerk, R. (2020), MicroRNA-132 regulates salt-dependent steady-state renin levels in mice, Communications Biology 3(1).
- Nijhoff, M.F.; Hovens, J.G.F.M.; Huisman, S.D.; Ringers, J.; Rabelink, T.A.J.; Fijter, H.J.W. de; Boog, P.J.M. van der & Koning, E.J.P. de (2020), Psychological symptoms and quality of life after simultaneous kidney and pancreas transplantation, Transplantation Direct 6(5).
- Dumas, S.J.; Meta, E.; Borri, M.; Goveia, J.; Rohlenova, K.; Conchinha, N.V.; Falkenberg, K.; Teuwen, L.A.; Rooij, L. de; Kalucka, J.; Chen, R.; Khan, S.; Taverna, F.; Lu, W.S.; Parys, M.; Legher, C. de; Vinckier, S.; Karakach, T.K.; Schoonjans, L.; Lin, L.; Bolund, L.; Dewerchin, M.; Eelen, G.; Rabelink, T.J.; Li, X.R.; Luo, Y.L. & Carmeliet, P. (2020), Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation, Journal of the American Society of Nephrology 31(1): 118-138.
- Trinanes, J.; Dijke, P. ten; Groen, N.; Hanegraaf, M.; Porrini, E.; Rodriguez-Rodriguez, A.E.; Drachenberg, C.; Rabelink, T.J.; Koning, E. de; Carlotti, F. & Vries, A.P.J. de (2020), Tacrolimus-Induced BMP/SMAD Signaling Associates With Metabolic Stress-Activated FOXO1 to Trigger beta-Cell Failure, Diabetes 69(2): 193-204.
- Deudekom, F.J. van; Kallenberg, M.H.; Berkhout-Byrne, N.C.; Blauw, G.J.; Boom, H.; Bresser, J. de; Buchem, M.A. van; Gaasbeek, A.; Hammer, S.; Lagro, J.; Osch, M.J.P. van; Witjes-Ane, M.N.; Rabelink, T.J.; Buren, M. van & Mooijaart, S.P. (2020), Patterns and characteristics of cognitive functioning in older patients approaching end stage kidney disease, the COPE-study, BMC Nephrology 21(1).
- Wang, G.Q.; Tiemeier, G.L.; Berg, B.M. van den & Rabelink, T.J. (2020), Endothelial glycocalyx hyaluronan: regulation and role in prevention of diabetic complications., The American Journal of Pathology 190(4).
- Wang, G.Q.; Kostidis, S.; Tiemeier, G.L.; Sol, W.M.P.J.; Vries, M.R. de; Giera, M.; Carmeliet, P.; Berg, B.M. van den & Rabelink, T.J. (2020), Shear stress regulation of endothelial glycocalyx structure is determined by glucobiosynthesis, Arteriosclerosis, Thrombosis, and Vascular Biology 40(2): 350-364.
- Imberti, B.; Cerullo, D.; Corna, D.; Rota, C.; Locatelli, M.; Pezzotta, A.; Introna, M.; Capelli, C.; Carminati, C.E.; Rabelink, T.J.; Leuning, D.G.; Zoja, C.; Morigi, M.; Remuzzi, G.; Benigni, A. & Luyckx, V. (2020), Protective effects of human nonrenal and renal stromal cells and their conditioned media in a rat model of chronic kidney disease, Cell Transplantation 29.
- Dekkers, I.A.; Vries, A.P.J. de; Smit, R.A.J.; Rosendaal, F.R.; Rabelink, T.J.; Lamb, H.J. & Mutsert, R. de (2020), The separate contributions of visceral fat and liver fat to chronic kidney disease-related renal outcomes, Journal of Renal Nutrition 30(4): 286-295.
- Dam, L.S. van; Dirikgil, E.; Bredewold, E.W.; Ray, A.; Bakker, J.A.; Kooten, C. van; Rabelink, T.J. & Teng, Y.K.O. (2020), Proteinase-3-anti-neutrophil cytoplasmic antibodies (PR3-ANCAs) predict relapses in ANCA-associated vasculitis patients after rituximab, Nephrology Dialysis Transplantation 36(8).
- Wang, G.Q.; Vries, M.R. de; Sol, W.M.P.J.; Oeveren-Rietdijk, A.M. van; Boer, H.C. de; Zonneveld, A.J. van; Quax, P.H.A.; Rabelink, T.J. & Berg, B.M. van den (2020), Loss of endothelial glycocalyx hyaluronan impairs endothelial stability and adaptive vascular remodeling after arterial ischemia, Cells 9(4).
- Dreyer, G.J.; Groeneweg, K.E.; Heidt, S.; Roelen, D.L.; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Bajema, I.M.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Kooten, C. van; Rabelink, R.J.; Fijter, J.W. de & Reinders, M.E.J. (2020), Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation, American Journal of Transplantation 20(10).
- Dam, L.S. van; Oskam, J.M.; Kamerling, S.W.A.; Arends, E.J.; Bredewold, O.W.; Berkowska, M.A.; Dongen, J.J.M. van; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2020), Highly sensitive flow cytometric detection of residual B-cells after rituximab in anti-neutrophil cytoplasmic antibodies-associated vasculitis patients, Frontiers in Immunology 11.
- Timal, R.J.; Kooiman, J.; Sijpkens, Y.W.J.; Vries, J.P.P.M. de; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Buren, M. van; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Jukema, J.W.; Rabelink, T.J. & Huisman, M.V. (2020), Effect of no prehydration vs sodium bicarbonate prehydration prior to contrast-enhanced computed tomography in the prevention of postcontrast acute kidney injury in adults with chronic kidney disease the Kompas randomized clinical trial, JAMA Internal Medicine 180(4): 533-541.
- Hermano, E.; Carlotti, F.; Abecassis, A.; Meirovitz, A.; Rubinstein, A.M.; Li, J.P.; Vlodavsky, I.; Rabelink, T.J. & Elkin, M. (2020), Dichotomic role of heparanase in a murine model of metabolic syndrome, Cellular and Molecular Life Sciences.
- Florijn, B.W.; Duijs, J.M.G.J.; Levels, J.H.; Dallinga-Thie, G.M.; Wang, Y.A.; Boing, A.N.; Yuana, Y.N.; Stam, W.; Limpens, R.W.A.L.; Au, Y.W.; Nieuwland, R.; Rabelink, T.J.; Reinders, M.E.J.; Zonneveld, A.J. van & Bijkerk, R. (2020), Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2 (vol 68, pg 2287, 2019), Diabetes 69(8): 1855-1855.
- Dam, L.S. van; Osmani, Z.; Kamerling, S.W.A.; Kraaij, T.; Bakker, J.A.; Scherer, H.U.; Rabelink, T.J.; Voll, R.E.; Alexander, T.; Isenberg, D.A.; Kooten, C. van & Teng, Y.K.O. (2020), A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE, Rheumatology 59(10): 2734-2745.
- Geelhoed, W.J.; Bogt, K.E.A. van der; Rothuizen, T.C.; Damanik, F.F.R.; Hamming, J.F.; Mota, C.D.; Agen, M.S. van; Boer, H.C. de; Restrepo, M.T.; Hinz, B.; Kislaya, A.; Poelma, C.; Zonneveld, A.J. van; Rabelink, T.J.; Moroni, L. & Rotmans, J.I. (2020), A novel method for engineering autologous non-thrombogenic in situ tissue-engineered blood vessels for arteriovenous grafting, Biomaterials 229.
- Dirikgil, E.; Tas, S.W.; Rutgers, A.; Verhoeven, P.M.J.; Laar, J.M. van; Hagen, E.C.; Tekstra, J.; Hak, A.E.L.; Paassen, P. van; Kok, M.R.; Goldschmeding, R.; Dam, B. van; Douma, C.E.; Remmelts, H.H.F.; Sanders, J.F.; Jonker, J.T.; Rabelink, T.J.; Damoiseaux, J.G.M.C.; Moens, H.J.B.; Bos, W.J.W.; Teng, Y.K.O. & Arthrit Res Collaboration Hub Cons (2020), A Dutch consensus statement on the diagnosis and treatment of ANC A-associated vasculitis, Netherlands Journal of Medicine 78(2): 71-82.
- Kraaij, T.; Arends, E.J.; Dam, L.S. van; Kamerling, S.W.A.; Daele, P.L.A. van; Bredewold, O.W.; Ray, A.; Bakker, J.A.; Scherer, H.U.; Huizinga, T.J.W.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2020), Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results, Nephrology Dialysis Transplantation 36(8).
- Tiemeier, G.L.; Koning, R. de; Wang, G.Q.; Kostidis, S.; Rietjens, R.G.J.; Sol, W.M.P.J.; Dumas, S.J.; Giera, M.; Berg, C.W. van den; Eikenboom, J.C.J.; Berg, B.M. van den; Carmeliet, P. & Rabelink, T.J. (2020), Lowering the increased intracellular pH of human-induced pluripotent stem cell-derived endothelial cells induces formation of mature Weibel-Palade bodies, Stem Cells Translational Medicine 9(7): 758-772.
- Koopman, J.J.E.; Teng, Y.K.O.; Boon, C.J.F.; Heuvel, L.P. van den; Rabelink, T.J.; Kooten, C. van & Vries, A.P.J. de (2019), Diagnosis and treatment of C3 glomerulopathy in a center of expertise, Netherlands Journal of Medicine 77(1): 10-18.
- Bijkerk, R.; Au, Y.W.; Stam, W.; Duijs, J.M.G.J.; Koudijs, A.; Lievers, E.; Rabelink, T.J. & Zonneveld, A.J. van (2019), Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis, Frontiers in Pharmacology 10.
- Wang, G.Q.; Kostidis, S.; Tiemeier, G.; Sol, W.; Giera, M.; Aird, W.; Rabelink, T. & Berg, B. van den (2019), Shear Stress Regulates Endothelial Glycocalyx Hyaluronan Biosynthesis Through HAS2 and Metabolic Regulation of Its Substrates, Journal of Vascular Research 56: 114-114.
- Trinanes, J.; Dijke, P. ten; Rabelink, T.J.; Koning, E.J. de; Carlotti, F. & Vries, A.P. de (2019), Tacrolimus Activated BMP Signaling Acts in Synergy with Stress-Activated FOXO1 to Induce Loss of Beta-Cell Function and Identity, American Journal of Transplantation 19: 960-961.
- Kok, M.J. de; McGuinness, D.; Shiels, P.G.; Vries, D.K. de; Nolthenius, J.B.T.; Wijermars, L.G.; Rabelink, T.J.; Verschuren, L.; Stevenson, K.S.; Kingsmore, D.B.; McBride, M.; Ploeg, R.J.; Bastiaannet, E.; Schaapherder, A.F. & Lindeman, J.H. (2019), The Neglectable Impact of Delayed Graft Function on Long-term Graft Survival in Kidneys Donated After Circulatory Death Associates With Superior Organ Resilience, Annals of Surgery 270(5): 877-883.
- Tiemeier, G.L.; Wang, G.Q.; Dumas, S.J.; Sol, W.M.P.J.; Avramut, M.C.; Karakach, T.; Orlova, V.V.; Berg, C.W. van den; Mummery, C.L.; Carmeliet, P.; Berg, B.M. van den & Rabelink, T.J. (2019), Closing the mitochondrial permeability transition pore in hiPSC-derived endothelial cells induces glycocalyx formation and functional maturation., Stem Cell Reports 13(5).
- Witjas, F.M.R.; Berg, B.M. van den; Berg, C.W. van den; Engelse, M.A. & Rabelink, T.J. (2019), Concise Review: The Endothelial Cell Extracellular Matrix Regulates Tissue Homeostasis and Repair, Stem Cells Translational Medicine 8(4): 375-382.
- Leuning, D.G.; Witjas, F.M.R.; Maanaoui, M.; Graaf, A.M.A. de; Lievers, E.; Geuens, T.; Avramut, C.M.; Wiersma, L.E.; Berg, C.W. van den; Sol, W.M.P.J.; Boer, H. de; Wang, G.Q.; LaPointe, V.L.S.; Vlag, J. van der; Kooten, C. van; Berg, B.M. van den; Little, M.H.; Engelse, M.A. & Rabelink, T.J. (2019), Vascular bioengineering of scaffolds derived from human discarded transplant kidneys using human pluripotent stem cell-derived endothelium, American Journal of Transplantation 19(5): 1328-1343.
- Bijkerk, R.; Aleksinskaya, M.A.; Duijs, J.M.G.J.; Veth, J.; Husen, B.; Reiche, D.; Prehn, C.; Adamski, J.; Rabelink, T.J.; Mey, J.G.R. de & Zonneveld, A.J. van (2019), Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation, Clinical Science 133(2): 239-252.
- Tin, A.; Marten, J.; Kuhns, V.L.H.; Li, Y.; Wuttke, M.; Kirsten, H.; Sieber, K.B.; Qiu, C.X.; Gorski, M.; Yu, Z.; Giri, A.; Sveinbjornsson, G.; Li, M.; Chu, A.Y.; Hoppmann, A.; O'Connor, L.J.; Prins, B.; Nutile, T.; Noce, D.; Akiyama, M.; Cocca, M.; Ghasemi, S.; Most, P.J. van der; Horn, K.; Xu, Y.Z.; Fuchsberger, C.; Sedaghat, S.; Afaq, S.; Amin, N.; Arnlo, J.; Bakker, S.J.L.; Bansal, N.; Baptista, D.; Bergmann, S.; Biggs, M.L.; Biino, G.; Boerwinkle, E.; Bottinger, E.P.; Boutin, T.S.; Brumat, M.; Burkhardt, R.; Campana, E.; Campbell, A.; Campbell, H.; Carroll, R.J.; Catamo, E.; Chambers, J.C.; Ciullo, M.; Concas, M.P.; Coresh, J.; Corre, T.; Cusi, D.; Felicita, S.C.; Borst, M.H. de; Grandi, A. de; Mutsert, R. de; Vries, A.P.J. de; Delgado, G.; Demirkan, A.; Devuyst, O.; Dittrich, K.; Eckardt, K.U.; Ehret, G.; Endlich, K.; Evans, M.K.; Gansevoort, R.T.; Gasparini, P.; Giedraitis, V.; Gieger, C.; Girotto, G.; Ggele, M.; Gordon, S.D.; Gudbjartsson, D.F.; Gudnason, V.; Haller, T.; Hamet, P.; Harris, T.B.; Hayward, C.; Hicks, A.A.; Hofer, E.; Holm, H.; Huang, W.; Hutri-Kahonen, N.; Hwang, S.J.; Ikram, M.A.; Lewis, R.M.; Ingelsson, E.; Jakobsdottir, J.; Jonsdottir, I.; Jonsson, H.; Joshi, P.K.; Josyula, N.S.; Jung, B.; Kahonen, M.; Kamatani, Y.; Kanai, M.; Kerr, S.M.; Kiess, W.; Kleber, M.E.; Koenig, W.; Kooner, J.S.; Korner, A.; Kovacs, P.; Kramer, B.K.; Kronenberg, F.; Kubo, M.; Kuhnel, B.; Bianca, M. la; Lange, L.A.; Lehne, B.; Lehtimaki, T.; Liu, J.; Loeffler, M.; Loos, R.J.F.; Lyytikainen, L.P.; Magi, R.; Mahajan, A.; Martin, N.G.; Marz, W.; Mascalzoni, D.; Matsuda, K.; Meisinger, C.; Meitinger, T.; Metspalu, A.; Milaneschi, Y.; ODonnell, C.J.; Wilson, O.D.; Gaziano, J.M.; Mishra, P.P.; Mohlke, K.L.; Mononen, N.; Montgomery, G.W.; Mook-Kanamori, D.O.; Muller-Nurasyid, M.; Nadkarni, G.N.; Nalls, M.A.; Nauck, M.; Nikus, K.; Ning, B.T.; Nolte, I.M.; Noordam, R.; O'Connell, J.R.; Olafsson, I.; Padmanabhan, S.; Penninx, B.W.J.H.; Perls, T.; Peters, A.; Pirastu, M.; Pirastu, N.; Pistis, G.; Polasek, O.; Ponte, B.; Porteous, D.J.; Poulain, T.; Preuss, M.H.; Rabelink, T.J.; Raffield, L.M.; Raitakari, O.T.; Rettig, R.; Rheinberger, M.; Rice, K.M.; Rizzi, F.; Robino, A.; Rudan, I.; Krajcoviechova, A.; Cifkova, R.; Rueedi, R.; Ruggiero, D.; Ryan, K.A.; Saba, Y.; Salvi, E.; Schmidt, H.; Schmidt, R.; Shaffer, C.M.; Smith, A.V.; Smith, B.H.; Spracklen, C.N.; Strauch, K.; Stumvoll, M.; Sulem, P.; Tajuddin, S.M.; Teren, A.; Thiery, J.; Thio, C.H.L.; Thorsteinsdottir, U.; Toniolo, D.; Tonjes, A.; Tremblay, J.; Uitterlinden, A.G.; Vaccargiu, S.; Harst, P. van der; Duijn, C.M. van; Verweij, N.; Volker, U.; Vollenweider, P.; Waeber, G.; Waldenberger, M.; Whitfield, J.B.; Wild, S.H.; Wilson, J.F.; Yang, Q.; Zhang, W.H.; Zonderman, A.B.; Bochud, M.; Wilson, J.G.; Pendergrass, S.A.; Ho, K.; Parsa, A.; Pramstaller, P.P.; Psaty, B.M.; Boger, C.A.; Snieder, H.; Butterworth, A.S.; Okada, Y.; Edwards, T.L.; Stefansson, K.; Susztak, K.; Scholz, M.; Heid, I.M.; Hung, A.M.; Teumer, A.; Pattaro, C.; Woodward, O.M.; Vitart, V.; Kottgen, A.; German Chronic Kidney Dis Study; Lifelines Cohort Study & VA Million Vet Program (2019), Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels, Nature Genetics 51(10): 1459-+.
- Jukema, J.W.; Timal, R.J.; Rotmans, J.I.; Hensen, L.C.R.; Buiten, M.S.; Bie, M.K. de; Putter, H.; Zwinderman, A.H.; Erven, L. van; Krol-van Straaten, M.J.; Hommes, N.; Gabreels, B.; Dorp, W. van; Dam, B. van; Herzog, C.A.; Schalij, M.J.; Rabelink, T.J. & ICD2 Trial Investigators (2019), Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients The Prospective, Randomized, Controlled ICD2 Trial, Circulation 139(23): 2628-2638.
- Rabelink, T.J. & Giera, M. (2019), New insights into energy and protein homeostasis by the kidney, Nature Reviews Nephrology 15(10): 596-598.
- Koning, M.; Berg, C.W. van den & Rabelink, T.J. (2019), Stem cell-derived kidney organoids: engineering the vasculature, Cellular and Molecular Life Sciences.
- Wuttke, M.; Li, Y.; Li, M.; Sieber, K.B.; Feitosa, M.F.; Gorski, M.; Tin, A.; Wang, L.H.; Chu, A.Y.; Hoppmann, A.; Kirsten, H.; Giri, A.; Chai, J.F.; Sveinbjornsson, G.; Tayo, B.O.; Nutile, T.; Fuchsberger, C.; Marten, J.; Cocca, M.; Ghasemi, S.; Xu, Y.Z.; Horn, K.; Noce, D.; Most, P.J. van der; Sedaghat, S.; Yu, Z.; Akiyama, M.; Afaq, S.; Ahluwalia, T.S.; Almgren, P.; Amin, N.; Arnlo, J.; Bakker, S.J.L.; Bansal, N.; Baptista, D.; Bergmann, S.; Biggs, M.L.; Biino, G.; Boehnke, M.; Boerwinkle, E.; Boissel, M.; Bottinger, E.P.; Boutin, T.S.; Brenner, H.; Brumat, M.; Burkhardt, R.; Butterworth, A.S.; Butterworth, A.S.; Campbell, A.; Campbell, H.; Canouil, M.; Carroll, R.J.; Catamo, E.; Chambers, J.C.; Chee, M.L.; Chee, M.L.; Chen, X.; Cheng, C.Y.; Cheng, Y.R.; Christensen, K.; Cifkova, R.; Ciullo, M.; Concas, M.P.; Cook, J.P.; Coresh, J.; Corre, T.; Sala, C.F.; Cusi, D.; Danesh, J.; Daw, E.W.; Borst, M.H.; Grandi, A.; Mutsert, R.; Vries, A.P.J.; Degenhardt, F.; Delgado, G.; Demirkan, A.; Angelantonio, E. di; Dittrich, K.; Divers, J.; Dorajoo, R.; Eckardt, K.U.; Ehret, G.; Elliott, P.; Endlich, K.; Evans, M.K.; Felix, J.F.; Foo, V.H.X.; Franco, O.H.; Franke, A.; Freedman, B.I.; Freitag-Wolf, S.; Friedlander, Y.; Froguel, P.; Gansevoort, R.T.; Gao, H.; Gasparini, P.; Gaziano, J.M.; Giedraitis, V.; Gieger, C.; Girotto, G.; Giulianini, F.; Gogele, M.; Gordon, S.D.; Gudbjartsson, D.F.; Gudnason, V.; Haller, T.; Hamet, P.; Harris, T.B.; Hartman, C.A.; Hayward, C.; Hellwege, J.N.; Heng, C.K.; Hicks, A.A.; Hofer, E.; Huang, W.; Hutri-Kahonen, N.; Hwang, S.J.; Ikram, M.A.; Indridason, O.S.; Ingelsson, E.; Ising, M.; Jaddoe, V.W.V.; Jakobsdottir, J.; Jonas, J.B.; Joshi, P.K.; Josyula, N.S.; Jung, B.; Kahonen, M.; Kamatani, Y.; Kammerer, C.M.; Kanai, M.; Kastarinen, M.; Kerr, S.M.; Khor, C.C.; Kiess, W.; Kleber, M.E.; Koenig, W.; Kooner, J.S.; Korner, A.; Kovacs, P.; Kraja, A.T.; Krajcoviechova, A.; Kramer, H.; Kramer, B.K.; Kronenberg, F.; Kubo, M.; Kuhnel, B.; Kuokkanen, M.; Kuusisto, J.; Bianca, M.; Laakso, M.; Lange, L.A.; Langefeld, C.D.; Lee, J.J.M.; Lehne, B.; Lehtimaki, T.; Lieb, W.; Lim, S.C.; Lind, L.; Lindgren, C.M.; Liu, J.; Liu, J.J.; Loeffler, M.; Loos, R.J.F.; Lucae, S.; Lukas, M.A.; Lyytikainen, L.P.; Magi, R.; Magnusson, P.K.E.; Mahajan, A.; Martin, N.G.; Martins, J.; Marz, W.; Mascalzoni, D.; Matsuda, K.; Meisinger, C.; Meitinger, T.; Melander, O.; Metspalu, A.; Mikaelsdottir, E.K.; Milaneschi, Y.; Miliku, K.; Mishra, P.P.; Program, V.A.M.V.; Mohlke, K.L.; Mononen, N.; Montgomery, G.W.; Mook-Kanamori, D.O.; Mychaleckyj, J.C.; Nadkarni, G.N.; Nalls, M.A.; Nauck, M.; Nikus, K.; Ning, B.; Nolte, I.M.; Noordam, R.; O'Connell, J.; O'Donoghue, M.L.; Olafsson, I.; Oldehinkel, A.J.; Orho-Melander, M.; Ouwehand, W.H.; Padmanabhan, S.; Palmer, N.D.; Palsson, R.; Penninx, B.W.J.H.; Perls, T.; Perola, M.; Pirastu, M.; Pirastu, N.; Pistis, G.; Podgornaia, A.I.; Polasek, O.; Ponte, B.; Porteous, D.J.; Poulain, T.; Pramstaller, P.P.; Preuss, M.H.; Prins, B.P.; Province, M.A.; Rabelink, T.J.; Raffield, L.M.; Raitakari, O.T.; Reilly, D.F.; Rettig, R.; Rheinberger, M.; Rice, K.M.; Ridker, P.M.; Rivadeneira, F.; Rizzi, F.; Roberts, D.J.; Robino, A.; Rossing, P.; Rudan, I.; Rueedi, R.; Ruggiero, D.; Ryan, K.A.; Saba, Y.; Sabanayagam, C.; Salomaa, V.; Salvi, E.; Saum, K.U.; Schmidt, H.; Schmidt, R.; Schottker,; Schulz, C.A.; Schupf, N.; Shaffer, C.M.; Shi, Y.; Smith, A.V.; Smith, B.H.; Soranzo, N.; Spracklen, C.N.; Strauch, K.; Stringham, H.M.; Stumvoll, M.; Svensson, P.O.; Szymczak, S.; Tai, E.S.; Tajuddin, S.M.; Tan, N.Y.Q.; Taylor, K.D.; Teren, A.; Tham, Y.C.; Thiery, J.; Thio, C.H.L.; Thomsen, H.; Thorleifsson, G.; Toniolo, D.; Tonjes, A.; Tremblay, J.; Tzoulaki, I.; Uitterlinden, A.G.; Vaccargiu, S.; Dam, R.M. van; Harst, P.D.; Duijn, C.M.; Edward, D.R.V.; Verweij, N.; Vogelezang, S.; Volker, U.; Vollenweider, P.; Waeber, G.; Waldenberger, M.; Wallentin, L.; Wang, Y.X.; Wang, C. & Waterwort (2019), A catalog of genetic loci associated with kidney function from analyses of a million individuals, Nature Genetics 51(6): 957-+.
- Dam, L. van; Oskam, J.; Kamerling, S.; Arends, E.; Bredewold, E.; Berkowska, M.; Dongen, J. van; Rabelink, T.; Kooten, C. van & Teng, O. (2019), Minimal Residual Autoimmunity After Rituximab in ANCA-associated Vasculitis Patients, Arthritis and Rheumatology 71.
- Esmeijer, K.; Vries, A.P. de; Mook-Kanamori, D.O.; Fijter, J.W. de; Rosendaal, F.R.; Rabelink, T.J.; Smit, R.A.J.; Mutsert, R. de & Hoogeveen, E.K. (2019), Low Birth Weight and Kidney Function in Middle-Aged Men and Women: The Netherlands Epidemiology of Obesity Study, American Journal of Kidney Diseases 74(6): 751-760.
- Dam, L.S. van; Kraaij, T.; Kamerling, S.W.A.; Bakker, J.A.; Scherer, U.H.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2019), Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus, Arthritis and Rheumatology.
- Balak, J.R.A.; Graaf, N. de; Zaldumbide, A.; Rabelink, T.J.; Hoeben, R.C.; Koning, E.J.P. de & Carlotti, F. (2019), Highly efficient ex vivo lentiviral transduction of primary human pancreatic exocrine cells, Scientific Reports 9.
- Berg, B.M. van den; Wang, G.Q.; Boels, M.G.S.; Avramut, M.C.; Jansen, E.; Sol, W.M.P.J.; Lebrin, F.; Zonneveld, A.J. van; Koning, E.J.P. de; Vink, H.; Grone, H.J.; Carmeliet, P.; Vlag, J. van der & Rabelink, T.J. (2019), Glomerular Function and Structural Integrity Depend on Hyaluronan Synthesis by Glomerular Endothelium, Journal of the American Society of Nephrology 30(10): 1886-1897.
- Teumer, A.; Li, Y.; Ghasemi, S.; Prins, B.P.; Wuttke, M.; Hermle, T.; Giri, A.; Sieber, K.B.; Qiu, C.X.; Kirsten, H.; Tin, A.; Chu, A.Y.; Bansal, N.; Feitosa, M.F.; Wang, L.; Chai, J.F.; Cocca, M.; Fuchsberger, C.; Gorski, M.; Hoppmann, A.; Horn, K.; Li, M.; Marten, J.; Noce, D.; Nutile, T.; Sedaghat, S.; Sveinbjornsson, G.; Tayo, B.O.; Most, P.J. van der; Xu, Y.Z.; Yu, Z.; Gerstner, L.; Arnlov, J.; Bakker, S.J.L.; Baptista, D.; Biggs, M.L.; Boerwinkle, E.; Brenner, H.; Burkhardt, R.; Carroll, R.J.; Chee, M.L.; Chee, M.L.; Chen, M.M.; Cheng, C.Y.; Cook, J.P.; Coresh, J.; Corre, T.; Danesh, J.; Borst, M.H. de; Grandi, A. de; Mutsert, R. de; Vries, A.P.J. de; Degenhardt, F.; Dittrich, K.; Divers, J.; Eckardt, K.U.; Ehret, G.; Endlich, K.; Felix, J.F.; Franco, O.H.; Franke, A.; Freedman, B.I.; Freitag-Wolf, S.; Gansevoort, R.T.; Giedraitis, V.; Gogele, M.; Grundner-Culemann, F.; Gudbjartsson, D.F.; Gudnason, V.; Hamet, P.; Harris, T.B.; Hicks, A.A.; Holm, H.; Foo, V.H.X.; Hwang, S.J.; Ikram, M.A.; Ingelsson, E.; Jaddoe, V.W.V.; Jakobsdottir, J.; Josyula, N.S.; Jung, B.; Kahonen, M.; Khor, C.C.; Kiess, W.; Koenig, W.; Korner, A.; Kovacs, P.; Kramer, H.; Kramer, B.K.; Kronenberg, F.; Lange, L.A.; Langefeld, C.D.; Lee, J.J.M.; Lehtimaki, T.; Lieb, W.; Lim, S.C.; Lind, L.; Lindgren, C.M.; Liu, J.J.; Loeffler, M.; Lyytikainen, L.P.; Mahajan, A.; Maranville, J.C.; Mascalzoni, D.; McMullen, B.; Meisinger, C.; Meitinger, T.; Miliku, K.; Mook-Kanamori, D.O.; Muller-Nurasyid, M.; Mychaleckyj, J.C.; Nauck, M.; Nikus, K.; Ning, B.; Noordam, R.; Connell, J.O.; Olafsson, I.; Palmer, N.D.; Peters, A.; Podgornaia, A.I.; Ponte, B.; Poulain, T.; Pramstaller, P.P.; Rabelink, T.J.; Raffield, L.M.; Reilly, D.F.; Rettig, R.; Rheinberger, M.; Rice, K.M.; Rivadeneira, F.; Runz, H.; Ryan, K.A.; Sabanayagam, C.; Saum, K.U.; Schottker, B.; Shaffer, C.M.; Shi, Y.; Smith, A.V.; Strauch, K.; Stumvoll, M.; Sun, B.B.; Szymczak, S.; Tai, E.S.; Tan, N.Y.Q.; Taylor, K.D.; Teren, A.; Tham, Y.C.; Thiery, J.; Thio, C.H.L.; Thomsen, H.; Thorsteinsdottir, U.; Tonjes, A.; Tremblay, J.; Uitterlinden, A.G.; Harst, P. van der; Verweij, N.; Vogelezang, S.; Volker, U.; Waldenberger, M.; Wang, C.; Wilson, O.D.; Wong, C.; Wong, T.Y.; Yang, Q.; Yasuda, M.; Akilesh, S.; Bochud, M.; Boger, C.A.; Devuyst, O.; Edwards, T.L.; Ho, K.; Morris, A.P.; Parsa, A.; Pendergrass, S.A.; Psaty, B.M.; Rotter, J.I.; Stefansson, K.; Wilson, J.G.; Susztak, K.; Snieder, H.; Heid, I.M.; Scholz, M.; Butterworth, A.S.; Hung, A.M.; Pattaro, C. & Kottgen, A. (2019), Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria, Nature Communications 10.
- Barbour, S.J.; Coppo, R.; Zhang, H.; Liu, Z.H.; Suzuki, Y.; Matsuzaki, K.; Katafuchi, R.; Er, L.; Espino-Hernandez, G.; Kim, S.J.; Reich, H.N.; Feehally, J.; Cattran, D.C.; Russo, M.L.; Troyanov, S.; Cook, H.T.; Roberts, I.; Tesar, V.; Maixnerova, D.; Lundberg, S.; Gesualdo, L.; Emma, F.; Fuiano, L.; Beltrame, G.; Rollino, C.; Amore, A.; Camilla, R.; Peruzzi, L.; Praga, M.; Feriozzi, S.; Polci, R.; Segoloni, G.; Colla, L.; Pani, A.; Piras, D.; Angioi, A.; Cancarini, G.; Ravera, S.; Durlik, M.; Moggia, E.; Ballarin, J.; Giulio, S. di; Pugliese, F.; Serriello, I.; Caliskan, Y.; Sever, M.; Kilicaslan, I.; Locatelli, F.; Vecchio, L. del; Wetzels, J.F.M.; Peters, H.; Berg, U.; Carvalho, F.; Ferreira, A.C.D.; Maggio, M.; Wiecek, A.; Ots-Rosenberg, M.; Magistroni, R.; Topaloglu, R.; Bilginer, Y.; D'Amico, M.; Stangou, M.; Giacchino, F.; Goumenos, D.; Kalliakmani, P.; Gerolymos, M.; Galesic, K.; Geddes, C.; Siamopoulos, K.; Balafa, O.; Galliani, M.; Stratta, P.; Quaglia, M.; Bergia, R.; Cravero, R.; Salvadori, M.; Cirami, L.; Fellstrorn, B.; Smerud, H.K.; Ferrario, F.; Stellato, T.; Egido, J.; Martin, C.; Floege, J.; Eitner, F.; Lupo, A.; Bernich, P.; Mene, R.; Morosetti, M.; Kooten, C. van; Rabelink, T.; Reinders, M.E.J.; Grinyo, J.M.B.; Cusinato, S.; Benozzi, L.; Savoldi, S.; Licata, C.; Mizerska-Wasiak, M.; Martina, G.; Messuerotti, A.; Canton, A. dal; Esposito, C.; Migotto, C.; Triolo, G.; Mariano, F.; Pozzi, C.; Boero, R.; Bellur, S.; Mazzucco, G.; Giannakakis, C.; Honsova, E.; Sundelin, B.; Palma, A.M. di; Ferrario, F.; Gutierrez, E.; Asunis, A.M.; Barratt, J.; Tardanico, R.; Perkowska-Ptasinska, A.; Terroba, J.A.; Fortunato, M.; Pantzaki, A.; Ozluk, Y.; Steenbergen, E.; Soderberg, M.; Riispere, Z.; Furci, L.; Orhan, D.; Kipgen, D.; Casartelli, D.; Ljubanovic, D.G.; Gakiopoulou, H.; Bertoni, E.; Ortiz, P.C.; Karkoszka, H.; Groene, H.J.; Stoppacciaro, A.; Bajema, I.; Bruijn, J.; Oliveras, X.F.; Maldyk, J.; Loachim, E.; Bavbek, N.; Cook, T.; Troyanov, S.; Alpers, C.; Amore, A.; Barratt, J.; Berthoux, F.; Bonsib, S.; Bruijn, J.; D'Agati, V.; D'Amico, G.; Emancipator, S.; Emmal, F.; Ferrario, F.; Fervenza, F.; Florquin, S.; Fogo, A.; Geddes, C.; Groene, H.; Haas, M.; Hill, P.; Hogg, R.; Hsu, S.; Hunley, T.; Hladunewich; Jennette, C.; Joh, K.; Julian, B.; Kawamura, T.; Lai, F.; Leung, C.; Li, L.; Li, P.; Liu, Z.; Massat, A.; Mackinnon, B.; Mezzano, S.; Schena, F.; Tomino, Y.; Walker, P.; Wang, H.; Weening, J.; Yoshikawa, N.; Zeng, C.H.; Shi, S.F.; Nogi, C.; Suzuki, H.; Koike, K.; Hirano, K.; Kawamura, T.; Yokoo, T.; Hanai, M.; Fukami, K.; Takahashi, K.; Yuzawa, Y.; Niwa, M.; Yasuda, Y.; Maruyama, S.; Ichikawa, D.; Suzuki, T.; Shirai, S.; Fukuda, A.; Fujimoto, S.; Trimarchi, H. & Int IgA Nephropathy Network (2019), Evaluating a New International Risk-Prediction Tool in IgA Nephropathy, JAMA Internal Medicine 179(7): 942-952.
- Florijn, B.W.; Duijs, J.M.G.J.; Levels, J.H.; Dallinga-Thie, G.M.; Wang, Y.N.; Boing, A.N.; Yuana, Y.; Stam, W.; Limpens, R.W.A.L.; Au, Y.W.; Nieuwland, R.; Rabelink, T.J.; Reinders, M.E.J.; Zonneveld, A.J. van & Bijkerk, R. (2019), Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2, Diabetes 68(12): 2287-2300.
- Tiemeier, G.L.; Wang, G.Q.; Dumas, S.J.; Sol, W.M.P.J.; Avramut, M.C.; Karakach, T.; Orlova, V.V.; Berg, C.W. van den; Mummery, C.L.; Carmeliet, P.; Berg, B.M. van den & Rabelink, T.J. (2019), Closing the Mitochondrial Permeability Transition Pore in hiPSC-Derived Endothelial Cells Induces Glycocalyx Formation and Functional Maturation, Stem Cell Reports 13(5): 803-816.
- Schroijen M, De Mutsert R, Rosendaal F, Rabelink T & Dekkers O (2019), Association of glucose metabolism and kidney function in middle-aged adults, Diabetologia 62: S481-S482.
- Dam, L. van; Dirikgil, E.; Bredewold, E.; Ray, A.; Rabelink, T.; Kooten, C. van & Teng, O. (2019), ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients, Arthritis and Rheumatology 71.
- Kraaij Tineke, Arends E. J., van Dam Laura, Kamerling Sylvia, van Daele Paul L. A., Bredewold Obbo Winne, Ray Argho, Bakker Jaap, Bajema Ingeborg, Scherer Hans Ulrich, Huizinga Thomas, Rabelink Ton, van Kooten Cees & Teng Y. K. Onno (2019), LONG-TERM EFFECTS OF SYNERGETIC B CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB COMBINATION TREATMENT IN SEVERE, REFRACTORY SLE: TWO YEAR RESULTS, Annals of the Rheumatic Diseases 78: 91-92.
- Arends, E.J.; Dam, L.S. van; Kraaij, T.; Kamerling, S.W.A.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2019), A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation, Journal of Visualized Experiments.
- Dam, L.S. van; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2019), Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases, Kidney International Reports 4(2): 196-211.
- Kok, M.J. de; McGuinness, D.; Shiels, P.G.; Vries, D.K. de; Nolthenius, J.B.T.; Wijermars, L.G.; Rabelink, T.J.; Verschuren, L.; Stevenson, K.S.; Kingsmore, D.B.; McBride, M.; Ploeg, R.J.; Bastiaannet, E.; Schaapherder, A.F. & Lindeman, J.H. (2019), The neglectable impact of delayed graft function on long-term graft survival in kidneys donated after circulatory death associates with superior organ resilience., Annals of Surgery 270(5).
- Arends, E.J.; Dam, L.S. van; Kraaij, T.; Kamerling, S.W.A.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2019), A high-throughput assay to assess and quantify neutrophil extracellular trap formation, Journal of Visualized Experiments 143.
- Rabelink, T.J. & Carmeliet, P. (2018), Glycolytic adaptation and progression of kidney disease, Nature Reviews Nephrology 14(2): 75-+.
- Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L.A. van; Bredewold, O.W.; Bakker, J.A.; Bajema, I.M.; Scherer, H.U.; Toes, R.E.M.; Huizinga, T.J.W.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2018), The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus, Journal of Autoimmunity 91: 45-54.
- Jonker, J.T.; Heer, P. de; Engelse, M.A.; Rossenberg, E.H. van; Klessens, C.Q.F.; Baelde, H.J.; Bajema, I.M.; Koopmans, S.J.; Coelho, P.G.; Streefland, T.C.M.; Webb, A.G.; Dekkers, I.A.; Rabelink, T.J.; Rensen, P.C.N.; Lamb, H.J. & Vries, A.P.J. de (2018), Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention, Nephrology Dialysis Transplantation 33(2): 224-230.
- van Dam Laura, Osmani Zgjim, Kraaij Tineke, Kamerling Sylvia, Bakker Jaap, Scherer Hans, Rabelink Ton, Voll Reinhard, Isenberg David, van Kooten Cees & Teng Y. (2018), THE EFFECT OF B CELL TARGETED THERAPIES ON AUTOANTIBODIES AND EXCESSIVE NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS, Nephrology Dialysis Transplantation 33.
- Gemst, J.J. van; Kouwenberg, M.; Rops, A.L.W.M.M.; Kuppevelt, T.H. van; Berden, J.H.; Rabelink, T.J.; Loeven, M.A. & Vlag, J. van der (2018), Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains, PLoS ONE 13(9).
- Dekkers, I.A.; Mutsert, R. de; Vries, A.P.J. de; Rosendaal, F.R.; Cannegieter, S.C.; Jukema, J.W.; Cessie, S. le; Rabelink, T.J.; Lamb, H.J. & Lijfering, W.M. (2018), Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population, Journal of Thrombosis and Haemostasis 16(3): 519-528.
- Thalgott, J.H.; Dos-Santos-Luis, D.; Hosman, A.E.; Martin, S.; Lamande, N.; Bracquart, D.; Srun, S.; Galaris, G.; Boer, H.C. de; Tual-Chalot, S.; Kroon, S.; Arthur, H.M.; Cao, Y.H.; Snijder, R.J.; Disch, F.; Mager, J.J.; Rabelink, T.J.; Mummery, C.L.; Raymond, K. & Lebrin, F. (2018), Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2, Circulation 138(23): 2698-2712.
- Aleksinskaya, M.A.; Monge, M.; Siebelt, M.; Slot, E.M.; Koekkoek, K.M.; Bruin, R.G. de; Massy, Z.A.; Weinans, H.; Rabelink, T.J.; Fibbe, W.E.; Zonneveld, A.J. van & Pel, M. van (2018), Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche, Scientific Reports 8.
- Dekkers, I.A.; Mutsert, R. de; Rabelink, T.J.; Jukema, J.W.; Roos, A. de; Rosendaal, F.R.; Lamb, H.J. & Vries, A.P.J. de (2018), Associations between normal range albuminuria, renal function and cardiovascular function in a population-based imaging study, Atherosclerosis 272: 94-100.
- Teng, Y.K.O.; Bredewold, E.O.W.; Rabelink, T.J.; Huizinga, T.W.J.; Eikenboom, H.C.J.; Limper, M.; Fritsch-Stork, R.D.E.; Bloemenkamp, K.W.M. & Sueters, M. (2018), An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus, Rheumatology 57(10): 1707-1720.
- Nijhoff MF, Huurman VAL, Dubbeld J, van Erkel AR, Rabelink TA, Engelse MA & de Koning EJP. (2018), Transplantation of islets of Langerhans: procedure, indications and challenges., Nederlands Tijdschrift voor Geneeskunde.
- Rota, C.; Morigi, M.; Cerullo, D.; Introna, M.; Colpani, O.; Corna, D.; Capelli, C.; Rabelink, T.J.; Leuning, D.G.; Rottoli, D.; Benigni, A.; Zoja, C. & Remuzzi, G. (2018), Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease, Stem Cell Research and Therapy 9.
- Leuning, D.G.; Beijer, N.R.M.; Fosse, N.A. du; Vermeulen, S.; Lievers, E.; Kooten, C. van; Rabelink, T.J. & Boer, J. de (2018), The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment, Scientific Reports 8.
- Berg, C.W. van den; Ritsma, L.; Avramut, M.C.; Wiersma, L.E.; Berg, B.M. van den; Leuning, D.G.; Lievers, E.; Koning, M.; Vanslambrouck, J.M.; Koster, A.J.; Howden, S.E.; Takasato, M.; Little, M.H. & Rabelink, T.J. (2018), Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo, Stem Cell Reports 10(3): 751-765.
- Kooiman, J.; Vries, J.P.P.M. de; Heyden, J. van der; Sijpkens, Y.W.J.; Dijkman, P.R.M. van; Wever, J.J.; Overhagen, H. van; Vahl, A.C.; Aarts, N.; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Hamming, J.F.; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Kilicsoy, I.; Rabelink, T.J. & Huisman, M.V. (2018), Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures, PLoS ONE 13(2).
- Bijkerk, R.; Trimpert, C.; Solingen, C. van; Bruin, R.G. de; Florijn, B.W.; Kooijman, S.; Berg, R. van den; Veer, E.P. van der; Bredewold, E.O.W.; Rensen, P.C.N.; Rabelink, T.J.; Humphreys, B.D.; Deen, P.M.T. & Zonneveld, A.J. van (2018), MicroRNA-132 controls water homeostasis through regulating MECP2-mediated vasopressin synthesis.
- Reinders, M.E.J.; Kooten, C. van; Rabelink, T.J. & Fijter, J.W. de (2018), Mesenchymal Stromal Cell Therapy for Solid Organ Transplantation, Transplantation 102(1): 35-43.
- Nijhoff, M.F.; Dubbeld, J.; Erkel, A.R. van; Boog, P.J.M. van der; Rabelink, T.J.; Engelse, M.A. & Koning, E.J.P. de (2018), Islet alloautotransplantation: Allogeneic pancreas transplantation followed by transplant pancreatectomy and islet transplantation, American Journal of Transplantation 18(4): 1016-1019.
- Loomans, C.J.M.; Giuliani, N.W.; Balak, J.; Ringnalda, F.; Gurp, L. van; Huch, M.; Boj, S.F.; Sato, T.; Kester, L.; Lopes, S.M.C.D.; Roost, M.S.; Bonner-Weir, S.; Engelse, M.A.; Rabelink, T.J.; Heimberg, H.; Vries, R.G.J.; Oudenaarden, A. van; Carlotti, F.; Clevers, H. & Koning, E.J.P. de (2018), Expansion of Adult Human Pancreatic Tissue Yields Organoids Harboring Progenitor Cells with Endocrine Differentiation Potential, Stem Cell Reports 10(3): 712-724.
- Kraaij, T.; Kamerling, S.W.A.; Dam, L.S. van; Bakker, J.A.; Bajema, I.M.; Page, T.; Brunini, F.; Pusey, C.D.; Toes, R.E.M.; Scherer, H.U.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2018), Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA, Kidney International 94(1): 139-149.
- Leuning, D.G.; Reinders, M.E.J.; Li, J.; Peired, A.J.; Lievers, E.; Boer, H.C. de; Fibbe, W.E.; Romagnani, P.; Kooten, C. van; Little, M.H.; Engelse, M.A. & Rabelink, T.J. (2017), Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine, Stem Cells Translational Medicine 6(2): 405-418.
- Berkhout-Byrne, N.; Kallenberg, M.H.; Gaasbeek, A.; Rabelink, T.J.; Hammer, S.; Buchem, M.A. van; Osch, M.J. van; Kroft, L.J.M.; Boom, H.; Mooijaart, S.P. & Buren, M. van (2017), The Cognitive decline in Older Patients with End stage renal disease (COPE) study - rationale and design, Current Medical Research and Opinion 33(11): 2057-2064.
- Malgo, F.; Hamdy, N.A.T.; Rabelink, T.J.; Kroon, H.M.; Claessen, K.M.J.A.; Pereira, A.M.; Biermasz, N.R. & Appelman-Dijkstra, N.M. (2017), Bone material strength index as measured by impact microindentation is altered in patients with acromegaly., European Journal of Endocrinology 176(3).
- Boels, M.G.S.; Koudijs, A.; Avramut, M.C.; Sol, W.M.P.J.; Wang, G.Q.; Oeveren-Rietdijk, A.M. van; Zonneveld, A.J. van; Boer, H.C. de; Vlag, J. van der; Kooten, C. van; Eulberg, D.; Berg, B.M. van den; IJpelaar, D.H.T. & Rabelink, T.J. (2017), Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy, The American Journal of Pathology 187(11): 2430-2440.
- Kraaij, T.; Kamerling, S.W.; Rooij, E. de; Daele, P.L. van; Bajema, I.; Bredewold, O.W.; Huizinga, T.W.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K. (2017), SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY, Annals of the Rheumatic Diseases 76: 871-871.
- Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L. van; Bredewold, O.W.; Bakker, J.A.; Bajema, I.; Scherer, H.U.; Toes, R.E.M.; Huizinga, T.W.J.; Rabelink, T.; Kooten, C. van & Teng, Y.K.O. (2017), Synergetic B-Cell Immunomodulation with Rituximab and Belimumab Combination Treatment in Severe, Refractory SLE, Arthritis and Rheumatology 69.
- Kraaij, T.; Kamerling, S.W.; Bakker, J.A.; Huizinga, T.W.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K. (2017), SIGNIFICANT REDUCTIONS OF PATHOGENIC AUTOANTIBODIES BY SYNERGETIC RITUXIMAB AND BELIMUMAB TREATMENT EFFECTIVELY INHIBITS NEUTROPHIL EXTRACELLULAR TRAPS IN SEVERE, REFRACTORY SLE - THE SYNBIOSE STUDY, Annals of the Rheumatic Diseases 76: 181-181.
- Rabelink, T.J. (2017), RENAL PHYSIOLOGY Burning calories to excrete salt, Nature Reviews Nephrology 13(6).
- Berkhout-Byrne, N.; Gaasbeek, A.; Mallat, M.J.K.; Rabelink, T.J.; Mooijaart, S.P.; Dekker, F.W. & Buren, M. van (2017), Regret about the decision to start dialysis: a cross-sectional Dutch national survey, Netherlands Journal of Medicine 75(6): 225-234.
- Chatzikyrkou, C.; Menne, J.; Izzo, J.; Viberti, G.; Rabelink, T.; Ruilope, L.M.; Rump, C.; Mertens, P.R. & Haller, H. (2017), Predictors for the development of microalbuminuria and interaction with renal function, Journal of Hypertension 35(12): 2501-2509.
- Ellenbroek, J.H.; Tons, H.A.M.; Hanegraaf, M.A.J.; Rabelink, T.J.; Engelse, M.A.; Carlotti, F. & Koning, E.J.P. de (2017), Pancreatic alpha-cell mass in obesity, Diabetes, Obesity and Metabolism 19(12): 1810-1813.
- Zonneveld, A.J. van; Rabelink, T.J. & Bijkerk, R. (2017), miRNA-Coordinated Networks as Promising Therapeutic Targets for Acute Kidney Injury, American Journal of Pathology 187(1): 20-24.
- Fibbe, W.E. & Rabelink, T.J. (2017), Mesenchymal stromal cells in lupus nephritis, Nature Reviews Nephrology 13(8): 453-454.
- Klessens, C.Q.F.; Zandbergen, M.; Wolterbeek, R.; Bruijn, J.A.; Rabelink, T.J.; Bajema, I.M. & IJpelaar, D.H.T. (2017), Macrophages in diabetic nephropathy in patients with type 2 diabetes, Nephrology Dialysis Transplantation 32(8): 1322-1329.
- Berg, B. van den; Wang, G.Q.; Cantelmo, A.R.; Kostidis, S.; Avramut, C.; Jansen, E.; Sol, W.; Lebrin, F.; Vlag, J. van der; Zonneveld, A.J. van; Koning, E. de; Groene, H.J.; Vink, H.; Carmeliet, P. & Rabelink, T. (2017), Loss Of Endothelial Glycocalyx Hyaluronan Upon Glycolytic Activation Results In Reduced Angiopoietin-1 Signaling And Vascular Destabilization, Journal of Vascular Research 54: 66-66.
- Rabelink, T.J.; Berg, B.M. van den; Garsen, M.; Wang, G.; Elkin, M. & Vlag, J. van der (2017), Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease, Nature Reviews Nephrology 13(4): 201-212.
- Dam, L. van; Kraaij, T.; Kamerling, S.; Scherer, H.U.; Pusey, C.; Rabelink, T.; Kooten, C. van & Teng, O. (2017), Ex Vivo Induced Neutrophil Extracellular Traps Are Intrinsically Different in Anca-Associated Vasculitis and Systemic Lupus Erythematosus, Arthritis and Rheumatology 69.
- Bruin, R.G. de; Rabelink, T.J.; Zonneveld, A.J. van & Veer, E.P. van der (2017), Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease, European Heart Journal 38(18): 1380-1388D.
- Hensen, L.C.R.; Delgado, V.; Wijngaarden, S.E. van; Leung, M.; Bie, M.K. de; Buiten, M.S.; Schalij, M.J.; Kerkhof, J.J. van de; Rabelink, T.J.; Rotmans, J.I.; Jukema, J.W. & Bax, J.J. (2017), Echocardiographic associates of atrial fibrillation in end-stage renal disease, Nephrology Dialysis Transplantation 32(8): 1409-1414.
- Boels, M.G.S.; Faassen, E.E.H. van; Avramut, M.C.; Vlag, J. van der; Berg, B.M. van den & Rabelink, T.J. (2017), Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy, PLoS ONE 12(1).
- Leuning, D.G.; Lievers, E.; Reinders, M.E.J.; Kooten, C. van; Engelse, M.A. & Rabelink, T.J. (2017), A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cellse, Journal of Visualized Experiments.
- Dam, L.S. van; Kraaij, T.; Kamerling, S.W.; Avramut, M.C.; Jost, C.R.; Koster, A.J.; Scherer, H.U.; Pusey, C.D.; Rabelink, A.J.; Kooten, C. van & Teng, Y.K. (2017), ANCA-ASSOCIATED VASCULITIS- AND SYSTEMIC LUPUS ERYTHEMATOSUS-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS HAVE INTRINSICALLY DIFFERENT FEATURES, Annals of the Rheumatic Diseases 76: 774-774.
- Bijkerk, R.; Florijn, B.W.; Khairoun, M.; Duijs, J.M.G.J.; Ocak, G.; Vries, A.P.J. de; Schaapherder, A.F.; Mallat, M.J.K.; Fijter, J.W. de; Rabelink, T.J.; Zonneveld, A.J. van & Reinders, M.E.J. (2017), Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury, Transplantation Direct 3(7).
- Bie, M.K. de; Buiten, M.S.; Rotmans, J.I.; Hogenbirk, M.; Schalij, M.J.; Rabelink, T.J. & Jukema, J.W. (2017), Abdominal aortic calcification on a plain X-ray and the relation with significant coronary artery disease in asymptomatic chronic dialysis patients, BMC Nephrology 18.
- Malgo, F.; Hamdy, N.A.T.; Ticheler, C.H.J.M.; Smit, F.; Kroon, H.M.; Rabelink, T.J.; Dekkers, O.M. & Appelman-Dijkstra, N.M. (2017), Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis, Osteoporosis International 28(10): 2955-2965.
- Leuning, D.G.; Engelse, M.A.; Lievers, E.; Bijkerk, R.; Reinders, M.E.J.; Boer, H.C. de; Kooten, C. van & Rabelink, T.J. (2017), The human kidney capsule contains a functionally distinct mesenchymal stromal cell population, PLoS ONE 12(12).
- Lint, C. van; Wang, W.X.; Dijk, S. van; Brinkman, W.P.; Rovekamp, T.J.M.; Neerincx, M.A.; Rabelink, T.J. & Boog, P.J.M. van der (2017), Self-Monitoring Kidney Function Post Transplantation: Reliability of Patient-Reported Data., JMIR 19(9).
- Kraaij, T.; Tengstrom, F.C.; Kamerling, S.W.A.; Pusey, C.D.; Scherer, H.U.; Toes, R.E.M.; Rabelink, T.J.; Kooten, C. van & Teng, Y.K.O. (2016), A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes, Autoimmunity Reviews 15(6): 577-584.
- Malgo, F.; Appelman-Dijkstra, N.M.; Termaat, M.F.; Heide, H.J.L. van der; Schipper, I.B.; Rabelink, T.J. & Hamdy, N.A.T. (2016), High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD., Archives of Osteoporosis.
- Boels, M.G.S.; Avramut, M.C.; Koudijs, A.; Dane, M.J.C.; Lee, D.H.; Vlag, J. van der; Koster, A.J.; Zonneveld, A.J. van; Faassen, E. van; Grone, H.J.; Berg, B.M. van den & Rabelink, T.J. (2016), Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy, Diabetes 65(8): 2429-2439.
- Garsen, M.; Rops, A.L.W.M.M.; Dijkman, H.; Willemsen, B.; Kuppevelt, T.H. van; Russel, F.G.; Rabelink, T.J.; Berden, J.H.M.; Reinheckel, T. & Vlag, J. van der (2016), Cathepsin L is crucial for the development of early experimental diabetic nephropathy, Kidney International 90(5): 1012-1022.
- Bezhaeva, T.; Geelhoed, W.J.; Alem, C.M.A. van; Damanik, F.R.; Rothuizen, T.C.; Lalai, R.A.; Koppen, A.N. van; Zonneveld, A.J. van; Rabelink, T.J.; Moroni, L. & Rotmans, J.I. (2016), CHRONIC KIDNEY DISEASE DOES NOT IMPACT THE MORPHOLOGY AND CELLULAR COMPOSITION OF IN VIVO TISSUE ENGINEERED BLOOD VESSELS IN RATS, Nephrology Dialysis Transplantation 31: 259-259.
- Garsen, M.; Rops, A.L.; Li, J.H.; Beneden, K. van; Branden, C. van den; Berden, J.H.M.; Rabelink, T.J. & Vlag, J. van der (2016), Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria, PLoS ONE 11(8).
- Garsen, M.; Lenoir, O.; Rops, A.L.W.M.M.; Dijkman, H.B.; Willemsen, B.; Kuppevelt, T.H. van; Rabelink, T.J.; Berden, J.H.M.; Tharaux, P.L. & Vlag, J. van der (2016), Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx, Journal of the American Society of Nephrology 27(12): 3545-3551.
- Kallenberg, M.H.; Kleinveld, H.A.; Dekker, F.W.; Munster, B.C. van; Rabelink, T.J.; Buren, M. van & Mooijaart, S.P. (2016), Functional and Cognitive Impairment, Frailty, and Adverse Health Outcomes in Older Patients Reaching ESRD-A Systematic Review, Clinical Journal of the American Society of Nephrology 11(9): 1624-1639.
- Garsen, M.; Benner, M.; Dijkman, H.B.; Kuppevelt, T.H. van; , J.P. lo; RabeLink, T.J.; Vlodavsky, I.; Berden, J.H.M.; Rops, A.L.W.M.M.; Elkin, M. & Vlag, J. van der (2016), Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis, American Journal of Pathology 186(4): 805-815.
- Malgo, F.; Appelman-Dijkstra, N.M.; Termaat, M.F.; Heide, H.J.L. van der; Schipper, I.B.; Rabelink, T.J. & Hamdy, N.A.T. (2016), High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD, Archives of Osteoporosis 11(1).
- Cantelmo, A.R.; Conradi, L.C.; Brajic, A.; Goveia, J.; Kalucka, J.; Pircher, A.; Chaturvedi, P.; Hol, J.; Thienpont, B.; Teuwen, L.A.; Schoors, S.; Boeckx, B.; Vriens, J.; Kuchnio, A.; Veys, K.; Cruys, B.; Finotto, L.; Treps, L.; Stav-Noraas, T.E.; Bifari, F.; Stapor, P.; Decimo, I.; Kampen, K.; Bock, K. de; Haraldsen, G.; Schoonjans, L.; Rabelink, T.; Eelen, G.; Ghesquiere, B.; Rehman, J.; Lambrechts, D.; Malik, A.B.; Dewerchin, M. & Carmeliet, P. (2016), Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy, Cancer Cell 30(6): 968-985.
- Wong, C.Y.; Bezhaeva, T.; Rothuizen, T.C.; Metselaar, J.M.; Vries, M.R. de; Verbeek, F.P.R.; Vahrmeijer, A.L.; Wezel, A.; Zonneveld, A.J. van; Rabelink, T.J.; Quax, P.H.A. & Rotmans, J.I. (2016), Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model, Scientific Reports 6.
- Vries, E.F. de; Rabelink, T.J. & Hout, W.B. van den (2016), Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease, Nephron 133(2): 89-97.
- Loeven, M.A.; Rops, A.L.; Lehtinen, M.J.; Kuppevelt, T.H. van; Daha, M.R.; Smith, R.J.; Bakker, M.; Berden, J.H.; Rabelink, T.J.; Jokiranta, T.S. & Vlag, J. van der (2016), Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro, Journal of Biological Chemistry 291(10): 4974-4981.
- Kooiman, J.; Hulle, T. van der; Maas, H.; Wiebe, S.; Formella, S.; Clemens, A.; Buren, M. van; Janssen, M.; Rabelink, T.J. & Huisman, M.V. (2016), Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease, Journal of the American College of Cardiology 67(20): 2442-2444.
- Bruin, R.G. de; Veer, E.P. van der; Prins, J.; Lee, D.H.; Dane, M.J.C.; Zhang, H.Y.; Roeten, M.K.; Bijkerk, R.; Boer, H.C. de; Rabelink, T.J.; Zonneveld, A.J. van & Gils, J.M. van (2016), The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and beta-catenin protein expression, Scientific Reports 6.
- Rothuizen, T.C.; Kemp, R.; Duijs, J.M.G.J.; Boer, H.C. de; Bijkerk, R.; Veer, E.P. van der; Moroni, L.; Zonneveld, A.J. van; Weiss, A.S.; Rabelink, T.J. & Rotmans, J.I. (2016), Promoting Tropoelastin Expression in Arterial and Venous Vascular Smooth Muscle Cells and Fibroblasts for Vascular Tissue Engineering, Tissue Engineering Part C Methods 22(10): 923-931.
- Bijkerk, R.; Bruin, R.G. de; Solingen, C. van; Gils, J.M. van; Duijs, J.M.G.J.; Veer, E.P. van der; Rabelink, T.J.; Humphreys, B.D. & Zonneveld, A.J. van (2016), Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation, Kidney International 89(6): 1268-1280.
- Gemst, J.J. van; Loeven, M.A.; Graaf, M.J.J. de; Berden, J.H.M.; Rabelink, T.J.; Smit, C.H. & Vlag, J. van der (2016), RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues, PLoS ONE 11(11).
- Bruin, R.G. de; Shiue, L.; Prins, J.; Boer, H.C. de; Singh, A.; Fagg, W.S.; Gils, J.M. van; Duijs, J.M.G.J.; Katzman, S.; Kraaijeveld, A.O.; Bohringer, S.; Leung, W.Y.; Kielbasa, S.M.; Donahue, J.P.; Zande, P.H.J. van der; Sijbom, R.; Alem, C.M.A. van; Bot, I.; Kooten, C. van; Jukema, J.W.; Esch, H. van; Rabelink, T.J.; Kazan, H.; Biessen, E.A.L.; Ares, M.; Zonneveld, A.J. van & Veer, E.P. van der (2016), Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression, Nature Communications 7.
- Wirix, A.J.G.; Nauta, J.; Groothoff, J.W.; Rabelink, T.J.; HiraSing, R.A.; Chinapaw, M.J.M. & Kist-van Holthel, J.E. (2016), Is the prevalence of hypertension in overweight children overestimated?, Archives of Disease in Childhood 101(11): 998-1003.
- Rothuizen, T.C.; Damanik, F.F.R.; Lavrijsen, T.; Visser, M.J.T.; Hamming, J.F.; Lalai, R.A.; Duijs, J.M.G.J.; Zonneveld, A.J. van; Hoefer, I.E.; Blitterswijk, C.A. van; Rabelink, T.J.; Moroni, L. & Rotmans, J.I. (2016), Development and evaluation of in vivo tissue engineered blood vessels in a porcine model, Biomaterials 75: 82-90.
- de Bruin RG, van der Veer EP, Prins J, Lee DH, Dane MJ, Zhang H, Roeten MK, Bijkerk R, de Boer HC, Rabelink TJ, van Zonneveld AJ & van Gils JM (2016), The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression., Scientific Reports.
- de Bruin RG, Shiue L, Prins J, de Boer HC, Singh A, Fagg WS, van Gils JM, Duijs JM, Katzman S, Kraaijeveld AO, Böhringer S, Leung WY, Kielbasa SM, Donahue JP, van der Zande PH, Sijbom R, van Alem CM, Bot I, van Kooten C, Jukema JW, Van Esch H, Rabelink TJ, Kazan H, Biessen EA, Ares M Jr, van Zonneveld AJ & van der Veer EP (2016), Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression., Nature Communications.
- Khairoun, M.; Heuvel, M. van den; Berg, B.M. van den; Sorop, O.; Boer, R. de; Ditzhuijzen, N.S. van; Bajema, I.M.; Baelde, H.J.; Zandbergen, M.; Duncker, D.J.; Rabelink, T.J.; Reinders, M.E.J.; Giessen, W.J. van der & Rotmans, J.I. (2015), Early Systemic Microvascular Damage in Pigs with Atherogenic Diabetes Mellitus Coincides with Renal Angiopoietin Dysbalance, PLoS ONE 10(4).
- External authors: Wenxin Wang, Willem-Paul Brinkman & Mark Neerincx: Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft. Ton JM Rövekamp: Department of Technology in Healthcare, Prevention and Health, Dutch Organization for Applied Scientific Research (TNO), Leiden. Sandra van Dijk: Department of Health, Medical and Neuropsychology, Faculty of Social and Behavioural Sciences, Leiden University & Leiden. (2015), Patient experiences with self-monitoring renal function after renal transplantation: results from a single-center prospective pilot study., Patient Preference and Adherence 9.
- External authors: Sandra van Dijk, Leiden University, Department of Health, Medical and Neuropsychology and Behavioural Sciences, Leiden, Netherlands Ton J.M. Rövekamp, Department of Technology in Healthcare, Prevention and Health, Dutch Organization for Applied Scientific Research (TNO), Leiden, The Netherlands Anja Kessler & Lothar Siekmann, Institute of Clinical Biochemistry and Pharmacology, University Hospital of Bonn, Bonn & Germany (2015), Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?, Clinical Chemistry and Laboratory Medicine 53(10).
- Kallenberg, M.H.; Gelder, J. de; Groot, B. de; Lucke, J.A.; Fogteloo, J.; Rabelink, T.J.; Buren, M. van & Mooijaart, S.P. (2015), COGNITIVE AND FUNCTIONAL DECLINE IN OLDER PATIENTS WITH IMPAIRED RENAL FUNCTION PRESENTING TO THE EMERGENCY DEPARTMENT, Nephrology Dialysis Transplantation 30.
- Dane, M.J.C.; Berg, B.M. van den; Lee, D.H.; Boels, M.G.S.; Tiemeier, G.L.; Avramut, M.C.; Zonneveld, A.J. van; Vlag, J. van der; Vink, H. & Rabelink, T.J. (2015), A microscopic view on the renal endothelial glycocalyx, AJP - Renal Physiology 308(9): F956-F966.
- Rothuizen, C.; Damanik, F.; Lavrijsen, T.; Visser, M.; Hamming, J.; Lalai, R.; Duijs, J.; Zonneveld, A. van; Hoefer, I.; Blitterswijk, C. van; Rabelink, T.; Moroni, L. & Rotmans, J. (2015), Development and Evaluation of an In Vivo Tissue Engineered Blood Vessel in a Porcine Model, Tissue Engineering: Parts A, B, and C 21: S82-S82.
- Rabelink, T.J. & Zeeuw, D. de (2015), The glycocalyx-linking albuminuria with renal and cardiovascular disease, Nature Reviews Nephrology 11(11): 667-676.
- Lint, C.L. van; Boog, P.J.M. van der; Wang, W.; Brinkman, W.P.; Rovekamp, T.J.M.; Neerincx, M.A.; Rabelink, T.J. & Dijk, S. van (2015), Patient experiences with self-monitoring renal function after renal transplantation: results from a single-center prospective pilot study, Patient Preference and Adherence 9: 1721-1731.
- Bijkerk, R.; Duijs, J.M.G.J.; Khairoun, M.; Horst, C.J.H. ter; Pol, P. van der; Mallat, M.J.; Rotmans, J.I.; Vries, A.P.J. de; Koning, E.J. de; Fijter, J.W. de; Rabelink, T.J.; Zonneveld, A.J. van & Reinders, M.E.J. (2015), Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas-Kidney Transplantation, American Journal of Transplantation 15(4): 1081-1090.
- Rothuizen, T.C.; Ocak, G.; Verschuren, J.J.W.; Dekker, F.W.; Rabelink, T.J.; Jukema, J.W. & Rotmans, J.I. (2015), Candidate Gene Analysis of Mortality in Dialysis Patients, PLoS ONE 10(11).
- Ray, A.; Huisman, M.V. & Rabelink, T.J. (2015), Can and should carotid ultrasound be used in cardiovascular risk assessment? The internist's perspective, European Journal of Internal Medicine 26(2): 112-117.
- Lint, C.L. van; Boog, P.J.M. van der; Romijn, F.P.H.T.M.; Schenk, P.W.; Dijk, S. van; Rovekamp, T.J.M.; Kessler, A.; Siekmann, L.; Rabelink, T.J. & Cobbaert, C.M. (2015), Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?, Clinical Chemistry and Laboratory Medicine 53(10): 1547-1556.
- Bank, J.R.; Rabelink, T.J.; Fijter, J.W. de & Reinders, M.E.J. (2015), Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients, Journal of Immunology Research.
- Spijker, H.S.; Song, H.; Ellenbroek, J.H.; Roefs, M.M.; Engelse, M.A.; Bos, E.; Koster, A.J.; Rabelink, T.J.; Hansen, B.C.; Clark, A.; Carlotti, F. & Koning, E.J.P. de (2015), Loss of beta-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits, Diabetes 64(8): 2928-2938.
- Buiten, M.S.; Bie, M.K. de; Rotmans, J.I.; Dekker, F.W.; Buren, M. van; Rabelink, T.J.; Cobbaert, C.M.; Schalij, M.J.; Laarse, A. van der & Jukema, J.W. (2015), Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease, PLoS ONE 10(8).
- Berkhout-Byrne, N.C.; Rabelink, T.J.; Mooijaart, S.P.; Gaasbeek, A. & Buren, M. van (2015), REGRET WITH THE DECISION TO START DIALYSIS IN OLDER PATIENTS: A DUTCH SURVEY AS QUALITY OF CARE INITIATIVE, Nephrology Dialysis Transplantation 30.
- Jonker, J.T.; Heer, P. de; Rossenberg, E.H. van; Engelse, M.A.; Streefland, T.C.M.; Rabelink, T.J.; Webb, A.G.; Rensen, P.C.N.; Lamb, H.J. & Vries, A.P.J. de (2015), IMAGING FATTY KIDNEY USING PROTON MR SPECTROSCOPY: VALIDATION BY PORCINE KIDNEY BIOPSIES, Nephrology Dialysis Transplantation 30.
- Garsen, M.; Sonneveld, R.; Rops, A.L.W.M.M.; Huntink, S.; Kuppevelt, T.H. van; Rabelink, T.J.; Hoenderop, J.G.J.; Berden, J.H.M.; Nijenhuis, T. & Vlag, J. van der (2015), Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte, Journal of Pathology 237(4): 472-481.
- Rothuizen, T.C.; Damanik, F.F.R.; Anderson, J.M.; Lavrijsen, T.; Cox, M.A.J.; Rabelink, T.J.; Moroni, L. & Rotmans, J.I. (2015), Tailoring the Foreign Body Response for In Situ Vascular Tissue Engineering.
- Wong, C.Y.; Rothuizen, T.C.; Vries, M.R. de; Rabelink, T.J.; Hamming, J.F.; Zonneveld, A.J. van; Quax, P.H.A. & Rotmans, J.I. (2015), Elastin is a Key Regulator of Outward Remodeling in Arteriovenous Fistulas, European Journal of Vascular and Endovascular Surgery 49(4): 480-486.
- Berkhout-Byrne, N.C.; Kallenberg, M.H.; Rabelink, T.J.; Mooijaart, S.P.; Gaasbeek, A. & Buren, M. van (2015), THE NEPHROGERIATRIC CLINICAL PATHWAY: A NEW APPROACH TO TREATING PRE-DIALYSIS ELDERLY PATIENTS IN THE NETHERLANDS, Nephrology Dialysis Transplantation 30.
- Kooiman, J.; Peppel, W.R. van de; Sijpkens, Y.W.J.; Brulez, H.F.H.; Vries, P.M. de; Nicolaie, M.A.; Putter, H.; Huisman, M.V.; Kooij, W. van der; Kooten, C. van & Rabelink, T.J. (2015), No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT, European Radiology 25(7): 1926-1934.
- Loeven, M.A.; Rops, A.L.W.M.M.; Berden, J.H.M.; Daha, M.R.; Rabelink, T.J. & Vlag, J. van der (2015), The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases, Molecular Immunology 63(2): 203-208.
- Strang Aart C., van Wijk Diederik F., Mutsaerts Henri J. M. M., Stroes Erik S. G., Nederveen Aart J., Rotmans Joris I., Rabelink Ton J. & Box Frieke M. A. (2015), Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus, Diabetes and Vascular Disease Research 12(2): 126-132.
- Solingen, C. van; Bijkerk, R.; Boer, H.C. de; Rabelink, T.J. & Zonneveld, A.J. van (2015), The Role of microRNA-126 in Vascular Homeostasis, Current Vascular Pharmacology 13(3): 341-351.
- Wong, C.Y.; Vries, M.R. de; Wang, Y.; Vorst, J.R. van der; Vahrmeijer, A.L.; Zonneveld, A.J. van; Roy-Chaudhury, P.; Rabelink, T.J.; Quax, P.H.A. & Rotmans, J.I. (2014), Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure, Journal of Vascular Surgery 59(1): 192-+.
- Garsen, M.; Rops, A.L.W.M.M.; Rabelink, T.J.; Berden, J.H.M. & Vlag, J. van der (2014), The role of heparanase and the endothelial glycocalyx in the development of proteinuria, Nephrology Dialysis Transplantation 29(1): 49-55.
- Buiten, M.S.; Bie, M.K. de; Rotmans, J.I.; Gabreels, B.A.; Dorp, W. van; Wolterbeek, R.; Trines, S.A.; Schalij, M.J.; Jukema, J.W.; Rabelink, T.J. & Erven, L. van (2014), The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients, Heart 100(9): 685-690.
- Muller, M. & Rabelink, T.J. (2014), Telomere shortening: a diagnostic tool and therapeutic target for cardiovascular disease?, European Heart Journal 35(46): 3245-3247.
- Rops, A.L.W.M.M.; Loeven, M.A.; Gemst, J.J. van; Eversen, I.; Wijk, X.M. van; Dijkman, H.B.; Kuppevelt, T.H. van; Berden, J.H.M.; Rabelink, T.J.; Esko, J.D. & Vlag, J. van der (2014), Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis, Kidney International 86(5): 932-942.
- Ellenbroek, J.H.; Dijck, L. van; Tons, H.A.; Rabelink, T.J.; Carlotti, F.; Ballieux, B.E.P.B. & Koning, E.J.P. de (2014), Long-term ketogenic diet causes glucose intolerance and reduced beta- and alpha-cell mass but no weight loss in mice, AJP - Endocrinology and Metabolism 306(5): E552-E558.
- Bijkerk, R.; Solingen, C. van; Boer, H.C. de; Pol, P. van der; Khairoun, M.; Bruin, R.G. de; Oeveren-Rietdijk, A.M. van; Lievers, E.; Schlagwein, N.; Gijlswijk, D.J. van; Roeten, M.K.; Neshati, Z.; Vries, A.A.F. de; Rodijk, M.; Pike-Overzet, K.; Berg, Y.W. van den; Veer, E.P. van der; Versteeg, H.H.; Reinders, M.E.J.; Staal, F.J.T.; Kooten, C. van; Rabelink, T.J. & Zonneveld, A.J. van (2014), eHematopoietic MicroRNA-126 Protects against Renal Ischemia/Reperfusion Injury by Promoting Vascular Integrity, Journal of the American Society of Nephrology 25(8): 1710-1722.
- Bijkerk, R.; Duijs, J.; Khairoun, M.; Horst, K. ter; Mallat, M.; Rotmans, J.; Vries, A. de; Koning, E. de; Fijter, H. de; Rabelink, T.; Zonneveld, A. van & Reinders, M. (2014), Circulating MicroRNAs Associate With Pathogenesis of Diabetic Nephropathy and Normalize After Simultaneous Pancreas-Kidney Transplantation., American Journal of Transplantation 14: 526-527.
- Buiten, M.S.; Bie, M.K. de; Heijden, A.C. van der; Rotmans, J.I.; Bootsma, M.; Groeneveld, J.H.M.; Wolterbeek, R.; Rabelink, T.J.; Jukema, J.W.; Schalij, M.J. & Erven, L. van (2014), Chronic Kidney Disease and Implantable Cardioverter Defibrillator Related Complications: 16 Years of Experience, Journal of Cardiovascular Electrophysiology 25(9): 998-1004.
- Dane, M.J.C.; Khairoun, M.; Lee, D.H.; Berg, B.M. van den; Eskens, B.J.M.; Boels, M.G.S.; Teeffelen, J.W.G.E. van; Rops, A.L.W.M.M.; Vlag, J. van der; Zonneveld, A.J. van; Reinders, M.E.J.; Vink, H. & Rabelink, T.J. (2014), Association of Kidney Function with Changes in the Endothelial Surface Layer, Clinical Journal of the American Society of Nephrology 9(4): 698-704.
- Kooiman, J.; Sijpkens, Y.W.J.; Vries, J.P.P.M. de; Brulez, H.F.H.; Hamming, J.F.; Molen, A.J. van der; Aarts, N.J.M.; Cannegieter, S.C.; Putter, H.; Swarts, R.; Hout, W.B. van den; Rabelink, T.J. & Huisman, M.V. (2014), A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography, Nephrology Dialysis Transplantation 29(5): 1029-1036.
- Leuning, D.; Reinders, M.; Lievers, E.; Duijs, J.; Zonneveld, A.J. van; Kooten, C. van; Engelse, M. & Rabelink, T. (2014), A NOVEL METHOD TO ISOLATE HUMAN KIDNEY DERIVED MESENCHYMAL STROMAL CELLS, Nephrology Dialysis Transplantation 29: 536-537.
- Roos, C.J.; Delgado, V.; Koning, E.J. de; Rabelink, T.J.; Jukema, J.W.; Bax, J.J. & Scholte, A.J. (2014), Associations of atherosclerosis in the descending thoracic aorta on CTA with arterial stiffness and chronic kidney disease in asymptomatic patients with diabetes mellitus, International Journal of Cardiovascular Imaging 30(6): 1151-1159.
- Kooiman, J.; Rein, N. van; Spaans, B.; Beers, K.A.J. van; Bank, J.R.; Peppel, W.R.V. de; Sol, A.I. del; Cannegieter, S.C.; Rabelink, T.J.; Lip, G.Y.H.; Klok, F.A. & Huisman, M.V. (2014), Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease, PLoS ONE 9(5).
- Lee, D.H.; Dane, M.J.C.; Berg, B.M. van den; Boels, M.G.S.; Teeffelen, J.W. van; Mutsert, R. de; Heijer, M. den; Rosendaal, F.R.; Vlag, J. van der; Zonneveld, A.J. van; Vink, H.; Rabelink, T.J. & NEO Study Grp (2014), Deeper Penetration of Erythrocytes into the Endothelial Glycocalyx Is Associated with Impaired Microvascular Perfusion, PLoS ONE 9(5).
- Reinders, M.E.J.; Fijter, J.W. de & Rabelink, T.J. (2014), Mesenchymal stromal cells to prevent fibrosis in kidney transplantation, Current Opinion in Organ Transplantation 19(1): 54-59.
- Dekkers, O.M.; Mummery, C.L. & Rabelink, T.J. (2014), A Case for Crowd Sourcing in Stem Cell Research, Stem Cells Translational Medicine 3(11): 1259-1261.
- Dane, M.; Berg, B. van den & Rabelink, T. (2014), The endothelial glycocalyx: Scratching the surface for cardiovascular disease in kidney failure, Atherosclerosis 235(1): 56-57.
- Kooiman, J.; Sijpkens, Y.W.J.; Buren, M. van; Groeneveld, J.H.M.; Ramai, S.R.S.; Molen, A.J. van der; Aarts, N.J.M.; Rooden, C.J. van; Cannegieter, S.C.; Putter, H.; Rabelink, T.J. & Huisman, M.V. (2014), Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography, Journal of Thrombosis and Haemostasis 12(10): 1658-1666.
- Nacak, H.; Diepen, M. van; Goeij, M.C.M. de; Rotmans, J.I.; Dekker, F.W. & PREPARE-2 Study Grp (2014), Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients, BMC Nephrology 15.
- Djaberi, R.; Schuijf, J.D.; Koning, E.J. de; Wijewickrama, D.C.; Pereira, A.M.; Smit, J.W.; Kroft, L.J.; Roos, A. de; Bax, J.J.; Rabelink, T.J. & Jukema, J.W. (2013), Non-invasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes, Diabetes and Vascular Disease Research 10(2): 123-134.
- Veer, E.P. van der; Bruin, R.G. de; Kraaijeveld, A.O.; Vries, M.R. de; Bot, I.; Pera, T.; Segers, F.M.; Trompet, S.; Gils, J.M. van; Roeten, M.K.; Beckers, C.M.; Santbrink, P.J. van; Janssen, A.; Solingen, C. van; Swildens, J.; Boer, H.C. de; Peters, E.A.; Bijkerk, R.; Rousch, M.; Doop, M.; Kuiper, J.; Schalij, M.J.; Wal, A.C. van der; Richard, S.; Berkel, T.J.C. van; Pickering, J.G.; Hiemstra, P.S.; Goumans, M.J.; Rabelink, T.J.; Vries, A.A.F. de; Quax, P.H.A.; Jukema, J.W.; Biessen, E.A.L. & Zonneveld, A.J. van (2013), Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype, Circulation Research 113(9): 1065-1075.
- Vries, D.K. de; Khairoun, M.; Lindeman, J.H.N.; Bajema, I.M.; Heer, E. de; Roest, M.; Zonneveld, A.J. van; Kooten, C. van; Rabelink, T.J.; Schaapherder, A.F. & Reinders, M.E.J. (2013), Renal Ischemia-Reperfusion Induces Release of Angiopoietin-2 From Human Grafts of Living and Deceased Donors, Transplantation 96(3): 282-289.
- Reinders, M.; Vries, D. de; Khairoun, M.; Lindeman, J.; Bajema, I.; Heer, E. de; Roest, M.; Zonneveld, A. van; Kooten, C. van; Schaapherder, A. & Rabelink, T. (2013), Renal Ischemia/Reperfusion Induces Release of Angiopoietin-2 from Human Grafts of Living and Deceased Donors., American Journal of Transplantation 13: 409-409.
- Khairoun, M.; Pol, P. van der; Vries, D.K. de; Lievers, E.; Schlagwein, N.; Boer, H.C. de; Bajema, I.M.; Rotmans, J.I.; Zonneveld, A.J. van; Rabelink, T.J.; Kooten, C. van & Reinders, M.E.J. (2013), Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis, American Journal of Physiology - Renal Physiology 305(6): F901-F910.
- Rabelink, T.J. & Little, M.H. (2013), Stromal cells in tissue homeostasis: balancing regeneration and fibrosis, Nature Reviews Nephrology 9(12): 747-753.
- Boels, M.G.S.; Lee, D.H.; Berg, B.M. van den; Dane, M.J.C.; Vlag, J. van der & Rabelink, T.J. (2013), The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome, European Journal of Internal Medicine 24(6): 503-509.
- Mutsert, R. de; Heijer, M. den; Rabelink, T.J.; Smit, J.W.A.; Romijn, J.A.; Jukema, J.W.; Roos, A. de; Cobbaert, C.M.; Kloppenburg, M.; Cessie, S. le; Middeldorp, S. & Rosendaal, F.R. (2013), The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection, European Journal of Epidemiology 28(6): 513-523.
- Reinders, M.E.J.; Rabelink, T.J. & Fijter, J.W. de (2013), The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation, Current Opinion in Organ Transplantation 18(1): 44-50.
- Reinders, M.; Fijter, J. de; Roelofs, H.; Vries, D. de; Claas, F.; Miert, P. van; Roelen, D.; Kooten, C. van & Rabelink, T. (2013), Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction., American Journal of Transplantation 13: 340-340.
- Rabelink, T.J. & Dahlke, M.H. (2013), Maximising impact of small cohort studies, Transplant International 26(9): 865-866.
- Roos, C.J.; Auger, D.; Djaberi, R.; Koning, E.J. de; Rabelink, T.J.; Pereira, A.M.; Bax, J.J.; Delgado, V.; Jukema, J.W. & Scholte, A.J. (2013), Relationship between left ventricular diastolic function and arterial stiffness in asymptomatic patients with diabetes mellitus, International Journal of Cardiovascular Imaging 29(3): 609-616.
- Spijker, H.S.; Ravelli, R.B.G.; Mommaas-Kienhuis, A.M.; Apeldoorn, A.A. van; Engelse, M.A.; Zaldumbide, A.; Bonner-Weir, S.; Rabelink, T.J.; Hoeben, R.C.; Clevers, H.; Mummery, C.L.; Carlotti, F. & Koning, E.J.P. de (2013), Conversion of Mature Human beta-Cells Into Glucagon-Producing alpha-Cells, Diabetes 62(7): 2471-2480.
- Dane, M.J.C.; Berg, B.M. van den; Avramut, M.C.; Faas, F.G.A.; Vlag, J. van der; Rops, A.L.W.M.M.; Ravelli, R.B.G.; Koster, B.J.; Zonneveld, A.J. van; Vink, H. & Rabelink, T.J. (2013), Glomerular Endothelial Surface Layer Acts as a Barrier against Albumin Filtration, American Journal of Pathology 182(5): 1532-1540.
- Willems, J.M.; Vlasveld, T.; Elzen, W.P.J. den; Westendorp, R.G.J.; Rabelink, T.J.; Craen, A.J.M. de & Blauw, G.J. (2013), Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old, BMC Geriatrics 13.
- Boer, H.C. de; Oeveren-Rietdijk, A.M. van; Rotmans, J.I.; Dekkers, O.M.; Rabelink, T.J. & Zonneveld, A.J. van (2013), Activated platelets correlate with mobilization of naive CD34(+) cells and generation of CD34(+)/KDR+ cells in the circulation. A meta-regression analysis, Journal of Thrombosis and Haemostasis 11(8): 1583-1592.
- Khairoun, M.; Ocak, G.; Rotmans, J.; Vries, A. de; Berg, B. van den; Lievers, E.; Mallat, M.; Vries, D. de; Zonneveld, A. van; Fijter, J. de; Rabelink, T. & Reinders, M. (2013), Acute Rejection Is Associated with Increased Microvascular Tortuosity and a Dysbalance in Angiopoietins up to 1 Year after Rejection., American Journal of Transplantation 13: 502-502.
- Rothuizen, T.C.; Wong, C.Y.; Quax, P.H.A.; Zonneveld, A.J. van; Rabelink, T.J. & Rotmans, J.I. (2013), Arteriovenous access failure: more than just intimal hyperplasia?, Nephrology Dialysis Transplantation 28(5): 1085-1092.
- Boer, H.C. de; Solingen, C. van; Prins, J.; Duijs, J.M.G.J.; Huisman, M.V.; Rabelink, T.J. & Zonneveld, A.J. van (2013), Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease, European Heart Journal 34(44): 3451-3457.
- Reinders, M.E.J.; Fijter, J.W. de; Roelofs, H.; Bajema, I.M.; Vries, D.K. de; Schaapherder, A.F.; Claas, F.H.J.; Miert, P.P.M.C. van; Roelen, D.L.; Kooten, C. van; Fibbe, W.E. & Rabelink, T.J. (2013), Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study, Stem Cells Translational Medicine 2(2): 107-111.
- Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E.; Fijter, J.W. de; Kooten, C. van; Rabelink, T.J. & Roelofs, H. (2013), Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy, Cytotherapy 15(6): 663-672.
- Verschuren, J.J.W.; Ocak, G.; Dekker, F.W.; Rabelink, T.J.; Jukema, J.W. & Rotmans, J.I. (2013), Candidate Gene Analysis of Arteriovenous Fistula Failure in Hemodialysis Patients, Clinical Journal of the American Society of Nephrology 8(8): 1358-1366.
- Monge, M.; Houben, T.; Boer, H. de; Aleksinskaya, M.; Massy, Z.; Rabelink, T.; Meijer, J.H. & Zonneveld, A.J. van (2013), Chronic renal failure does not affect the mouse locomotor activity in darkness conditions, Biological Rhythm Research 44(5): 771-777.
- Bijkerk, R.; Khairoun, M.; Duijs, J.; Horst, K. ter; Vries, A. de; Koning, E. de; Fijter, J. de; Rabelink, T.; Zonneveld, A. van & Reinders, M. (2013), Circulating MicroRNAs Correlate with Diabetic Nephropathy and Systemic Microvascular Damage and Normalize after Simultaneous Pancreas-Kidney Transplantation., American Journal of Transplantation 13: 440-440.
- Gast, K.B.; Smit, J.W.A.; Heijer, M. den; Middeldorp, S.; Rippe, R.C.A.; Cessie, S. le; Koning, E.J.P. de; Jukema, J.W.; Rabelink, T.J.; Roos, A. de; Rosendaal, F.R.; Mutsert, R. de & NEO Study Grp (2013), Abdominal adiposity largely explains associations between insulin resistance, hyperglycemia and subclinical atherosclerosis: The NEO study, Atherosclerosis 229(2): 423-429.
- Daleboudt, G.M.N.; Reinders, M.E.J.; Hartigh, J. den; Huizinga, T.W.J.; Rabelink, A.J.; Fijter, J.W. de & Berger, S.P. (2013), Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil, Lupus 22(2): 171-179.
- Bie, M.K. de; Buiten, M.S.; Gaasbeek, A.; Boogers, M.J.; Roos, C.J.; Schuijf, J.D.; Krol, M.J.; Rabelink, T.J.; Bax, J.J.; Schalij, M.J. & Jukema, J.W. (2013), CT Coronary Angiography Is Feasible for the Assessment of Coronary Artery Disease in Chronic Dialysis Patients, Despite High Average Calcium Scores, PLoS ONE 8(7).
- Bie, M.K. de; Marsan, N.A.; Gaasbeek, A.; Bax, J.J.; Delgado, V.; Rabelink, T.J.; Schalij, M.J. & Jukema, J.W. (2013), Echocardiographical determinants of an abnormal spatial QRS-T angle in chronic dialysis patients, Nephrology Dialysis Transplantation 28(12): 3045-3052.
- Lee, D.H.; Dane, M.J.C.; Berg, B. van den; Boels, M.G.S.; Teeffelen, J. van; Heijer, M. den; Rosendaal, F.; Vink, H.; Zonneveld, A.J. van & Rabelink, T.J. (2013), ENDOTHELIA GLYCOCALYX ACCESSIBILITY DETERMINES MICROVASCULAR PERFUSION AND METABOLIC BALANCE IN OBESITY, Journal of Vascular Research 50: 22-22.
- Ellenbroek, J.H.; Tons, H.A.M.; Meeteren, M.J.A.W. van; Graaf, N. de; Hanegraaf, M.A.; Rabelink, T.J.; Carlotti, F. & Koning, E.J.P. de (2013), Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice, Diabetologia 56(9): 1980-1986.
- Aleksinskaya, M.A.; Faassen, E.E.H. van; Nelissen, J.; Janssen, B.J.A.; Mey, J.G.R. de; Hanemaaijer, R.; Rabelink, T. & Zonneveld, A.J. van (2013), Identification of Free Nitric Oxide Radicals in Rat Bone Marrow: Implications for Progenitor Cell Mobilization in Hypertension, PLoS ONE 8(3).
- Mourer, J.S.; Koning, E.J.P. de; Zwet, E.W. van; Mallat, M.J.K.; Rabelink, T.J. & Fijter, J.W. de (2013), Impact of Late Calcineurin Inhibitor Withdrawal on Ambulatory Blood Pressure and Carotid Intima Media Thickness in Renal Transplant Recipients, Transplantation 96(1): 49-57.
- Bie, M.K. de; Koopman, M.G.; Gaasbeek, A.; Dekker, F.W.; Maan, A.C.; Swenne, C.A.; Scherptong, R.W.; Dessel, P.F. van; Wilde, A.A.; Schalij, M.J.; Rabelink, T.J. & Jukema, J.W. (2013), Incremental prognostic value of an abnormal baseline spatial QRS-T angle in chronic dialysis patients, EP-Europace 15(2): 290-296.
- Franquesa, M.; Hoogduijn, M.J.; Reinders, M.E.; Eggenhofer, E.; Engela, A.U.; Mensah, F.K.; Torras, J.; Pileggi, A.; Kooten, C. van; Mahon, B.; Detry, O.; Popp, F.C.; Benseler, V.; Casiraghi, F.; Johnson, C.; Ancans, J.; Fillenberg, B.; delaRosa, O.; Aran, J.M.; Roemeling-vanRhijn, M.; Pinxteren, J.; Perico, N.; Gotti, E.; Christ, B.; Reading, J.; Introna, M.; Deans, R.; Shagidulin, M.; Farre, R.; Rambaldi, A.; Sanchez-Fueyo, A.; Obermajer, N.; Pulin, A.; Dor, F.J.M.F.; Portero-Sanchez, I.; Baan, C.C.; Rabelink, T.J.; Remuzzi, G.; Betjes, M.G.H.; Dahlke, M.H.; Grinyo, J.M. & MiSOT Study Grp (2013), Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: Lessons Learned from First Clinical Trials, Transplantation 96(3): 234-238.
- Hammer, S.; Vries, A.P.J. de; Heer, P. de; Bizino, M.B.; Wolterbeek, R.; Rabelink, T.J.; Doornbos, J. & Lamb, H.J. (2013), Metabolic Imaging of Human Kidney Triglyceride Content: Reproducibility of Proton Magnetic Resonance Spectroscopy, PLoS ONE 8(4).
- Khairoun, M.; Koning, E.J.P. de; Berg, B.M. van den; Lievers, E.; Boer, H.C. de; Schaapherder, A.F.M.; Mallat, M.J.K.; Rotmans, J.I.; Boog, P.J.M. van der; Zonneveld, A.J. van; Fijter, J.W. de; Rabelink, T.J. & Reinders, M.E.J. (2013), Microvascular Damage in Type 1 Diabetic Patients Is Reversed in the First Year After Simultaneous Pancreas-Kidney Transplantation, American Journal of Transplantation 13(5): 1272-1281.
- Oliveira, C.C.; Querido, B.; Sluijter, M.; Groot, A.F. de; Zee, R. van der; Rabelink, M.J.W.E.; Hoeben, R.C.; Ossendorp, F.; Burg, S.H. van der & Hall, T. van (2013), New Role of Signal Peptide Peptidase To Liberate C-Terminal Peptides for MHC Class I Presentation, Journal of Immunology 191(8): 4020-4028.
- de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, Rabelink AJ & van Zonneveld AJ (2013), Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease, European Heart Journal 34(44).
- Aydin, Z.; Mallat, M.J.K.; Schaapherder, A.F.M.; Zonneveld, A.J. van; Kooten, C. van; Rabelink, T.J. & Fijter, J.W. de (2012), Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients, American Journal of Transplantation 12(7): 1793-1800.
- Pel, M. van; Galarza, J.P.; Carlotti, F.; Rabelink, M.; Cramer, S.; Hoeben, R. & Fibbe, W. (2012), CONSTRUCT OPTIMIZATION ALLOWS LIVE IMAGING OF IFN-1 STIMULATED MSC BY BIOLUMINESCENCE IMAGING IN VIVO, Experimental Hematology 40(8): S160-S160.
- Khairoun, M.; Berg, B.M. van den; Timal, R.; Lievers, E.; Schaapherder, A.F.; Zonneveld, A.J. van; Fijter, J.W. de; Rabelink, T.J. & Reinders, M.E.J. (2012), Improvement of Microvascular Damage after Living Donor Kidney-Transplantation, American Journal of Transplantation 12: 504-504.
- Ellenbroek, J.H.; Tons, H.A.; Graaf, N. de; Loomans, C.J.M.; Engelse, M.A.; Vrolijk, H.; Rabelink, T.J.; Carlotti, F. & Koning, E.J.P. de (2012), Beta cell adaptation is topologically heterogeneous throughout the pancreas, Diabetologia 55: S183-S183.
- Bie, M.K. de; Buiten, M.S.; Rabelink, T.J. & Jukema, J.W. (2012), Republished: How to reduce sudden cardiac death in patients with renal failure, Postgraduate Medical Journal 88(1041): 418-424.
- Menne, J.; Izzo, J.L.; Ito, S.; Januszewicz, A.; Katayama, S.; Chatzykirkou, C.; Mimran, A.; Rabelink, T.J.; Ritz, E.; Ruilope, L.M.; Rump, L.C.; Viberti, G.; Haller, H. & ROADMAP Investigators (2012), Prevention of microalbuminuria in patients with type 2 diabetes and hypertension, Journal of Hypertension 30(4): 811-818.
- Buiten, M.S.; Bie, M.K. de; Rotmans, J.; Erven, L. van; Rabelink, A.J.; Schalij, M.J. & Jukema, J.W. (2012), Is the high prevelance of atrial fibrillation in end stage renal disease related to the hemodialysis procedure itself?, European Heart Journal 33: 374-374.
- Klop, B.; Jukema, J.W.; Rabelink, T.J. & Cabezas, M.C. (2012), A physician's guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy, Panminerva Medica 54(2): 91-103.
- Vries, A.P.J. de & Rabelink, T.J. (2012), A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome.
- Asgeirsdottir, S.A.; Solingen, C. van; Kurniati, N.F.; Zwiers, P.J.; Heeringa, P.; Meurs, M. van; Satchell, S.C.; Saleem, M.A.; Mathieson, P.W.; Banas, B.; Kamps, J.A.A.M.; Rabelink, T.J.; Zonneveld, A.J. van & Molema, G. (2012), MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation, AJP - Renal Physiology 302(12): F1630-F1639.
- Schulte, B.M.; Lanke, K.H.W.; Piganelli, J.D.; Kers-Rebel, E.D.; Bottino, R.; Trucco, M.; Huijbens, R.J.F.; Radstake, T.R.D.J.; Engelse, M.A.; Koning, E.J.P. de; Galama, J.M.; Adema, G.J. & Kuppeveld, F.J.M. van (2012), Cytokine and Chemokine Production by Human Pancreatic Islets Upon Enterovirus Infection, Diabetes 61(8): 2030-2036.
- Faas, F.G.A.; Avramut, M.C.; Berg, B.M. van den; Mommaas, A.M.; Koster, A.J. & Ravelli, R.B.G. (2012), Virtual nanoscopy: Generation of ultra-large high resolution electron microscopy maps.
- Bie, M.K. de; Buiten, M.S.; Rabelink, T.J. & Jukema, J.W. (2012), How to reduce sudden cardiac death in patients with renal failure, Heart 98(4): 335-341.
- Boertien, W.E.; Meijer, E.; Zittema, D.; Dijk, M.A. van; Rabelink, T.J.; Breuning, M.H.; Struck, J.; Bakker, S.J.L.; Peters, D.J.M.; Jong, P.E. de & Gansevoort, R.T. (2012), Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
- Cerezo, C.; Ruilope, L.M.; Segura, J.; Garcia-Donaire, J.A.; Cruz, J.J. de la; Banegas, J.R.; Waeber, B.; Rabelink, T.J. & Messerli, F.H. (2012), Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression, Journal of Hypertension 30(1): 204-209.
- Mourer, J.S.; Ewe, S.H.; Mallat, M.J.K.; Ng, A.C.T.; Rabelink, T.J.; Bax, J.J.; Delgado, V. & Fijter, J.W. de (2012), Late Calcineurin Inhibitor Withdrawal Prevents Progressive Left Ventricular Diastolic Dysfunction in Renal Transplant Recipients, Transplantation 94(7): 721-728.
- Lint, C. van; Dijk, S. van; Rabelink, T. & Boog, P. van der (2012), Patients' experiences with an internet-based Disease Management System to self-monitor kidney function after transplantation, Psychology and Health 27: 133-133.
- Roos, C.; Auger, D.; Djaberi, R.; Koning, E.J. de; Rabelink, T.J.; Smit, J.W.; Pereira, A.M.; Bax, J.; Delgado, V.; Jukema, J. & Scholte, A. (2012), ASSOCIATIONS BETWEEN LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND VASCULAR STIFFNESS AS ASSESSED WITH APPLANATION TONOMETRY IN ASYMPTOMATIC PATIENTS WITH DIABETES, Journal of the American College of Cardiology 59(13): E1674-E1674.
- Rotmans, J.I. & Rabelink, T.J. (2012), Antenatal excessive sodium intake induces adverse vascular remodelling in offspring.
- Vries, D.K. de; Roest, M.; Khairoun, M.; Lindeman, J.H.; Ringers, J.; Rabelink, T.J.; Groot, P.G. de; Reinders, M.E. & Schaapherder, A.F. (2011), ENDOTHELIAL AND THROMBOCYTE ACTIVATION ARE NOT MEDIATORS IN EARLY ISCHEMIA-REPERFUSION INJURY IN HUMAN KIDNEY TRANSPLANTATION.
- Lindeman, J.H.N.; Rabelink, T.J. & Bockel, J.H. van (2011), Immunosuppression and the Abdominal Aortic Aneurysm Doctor Jekyll or Mister Hyde?, Circulation 124(18): E463-E465.
- Monge, M.; Massy, Z.A.; Zonneveld, A.J. van & Rabelink, T.J. (2011), Endothelial progenitor cells: What are we talking about?, Néphrologie and Thérapeutique 7(7): 521-525.
- Siezenga, M.A.; Shaw, P.K.C.; Daha, M.R.; Rabelink, T.J. & Berger, S.P. (2011), Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study, Cardiovascular Diabetology 10: -.
- Boer, H.C. de; Hovens, M.M.; Oeveren-Rietdijk, A.M. van; Snoep, J.D.; Koning, E.J.P. de; Tamsma, J.T.; Huisman, M.V.; Rabelink, A.J. & Zonneveld, A.J. van (2011), Human CD34(+)/KDR+ Cells Are Generated From Circulating CD34(+) Cells After Immobilization on Activated Platelets, Arteriosclerosis, Thrombosis, and Vascular Biology 31(2): 408U370.
- Wijk, J.P.H. van; Hoepelman, A.I.M.; Koning, E.J.P. de; Dallinga-Thie, G.; Rabelink, T.J. & Cabezas, M.C. (2011), Differential Effects of Rosiglitazone and Metformin on Postprandial Lipemia in Patients With HIV-Lipodystrophy, Arteriosclerosis, Thrombosis, and Vascular Biology 31(1): 228-233.
- Solingen, C. van; Boer, H.C. de; Bijkerk, R.; Monge, M.; Oeveren-Rietdijk, A.M. van; Seghers, L.; Vries, M.R. de; Veer, E.P. van der; Quax, P.H.A.; Rabelink, T.J. & Zonneveld, A.J. van (2011), MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia., Cardiovascular Research 92(3): 449-55.
- Roos, C.J.; Djaberi, R.; Schuijf, J.D.; Koning, E.J. de; Rabelink, T.J.; Smit, J.W.; Pereira, A.M.; Younis, I. al; Hiel, B. van der; Scholte, A.J.; Bax, J.J. & Jukema, J.W. (2011), Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes, European Journal of Nuclear Medicine and Molecular Imaging 38(11): 2050-2057.
- Boer, H.C. de; Hovens, M.M.; Oeveren-Rietdijk, A.M. van; Snoep, J.D.; Koning, E.J.P. de; Tamsma, J.T.; Huisman, M.V.; Rabelink, A.J. & Zonneveld, A.J. van (2011), Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets.
- Aydin, Z.; Dubbeld, J.; Mallat, M.J.; Ringers, J.; Rabelink, T.J. & Fijter, J.W. de (2011), PROSPECTIVE TRIAL ON ERYTHROPOIETIN IN CLINICAL TRANSPLANTATION.
- Kort, H. de; Koning, E.J. de; Rabelink, T.J.; Bruijn, J.A. & Bajema, I.M. (2011), Islet transplantation in type 1 diabetes, British medical journal 342.
- Bie, M.K. de; Marsan, N.A.; Gaasbeek, A.; Groeneveld, J.H.M.; Gabreels, B.A.; Rabelink, T.J.; Bax, J.J.; Schalij, M.J. & Jukema, J.W. (2011), Left Ventricular Diastolic Dysfunction in Dialysis Patients Assessed by Novel Speckle Tracking Strain Rate Analysis: Prevalence and Determinants, Circulation 124(21): -.
- Rabelink, T.J.; Kohan, D.E.; Barton, M. & Kohan, D.E. (2011), Endothelin Receptor Blockade in Patients with Diabetic Nephropathy, ENDOTHELIN IN RENAL PHYSIOLOGY AND DISEASE 172: 235-242.
- Bie, M.K. de; Rees, J.B. van; Herzog, C.A.; Rabelink, T.J.; Schalij, M.J. & Jukema, J.W. (2011), How to reduce the incidence of contrast induced acute kidney injury after cardiac (invasive) procedures, a review and practical recommendations, Current Medical Research and Opinion 27(7): 1347-1357.
- Monge, M.; Massy, Z.A.; Zonneveld, A.J. van & Rabelink, T.J. (2011), [Endothelial progenitor cells: What are we talking about?], Néphrologie and Thérapeutique.
- Haller, H.; Ito, S.; Izzo, J.L.; Januszewicz, A.; Katayama, S.; Menne, J.; Mimran, A.; Rabelink, T.J.; Ritz, E.; Ruilope, L.M.; Rump, L.C.; Viberti, G. & ROADMAP Trial Investigators (2011), Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
- Aydin, Z.; Dubbeld, J.; Mallat, M.J.; Ringers, J.; Rabelink, T.J. & Fijter, J.W. de (2011), PROspective Trial on Erythropoietin in Clinical Transplantation., American Journal of Transplantation 11: 36-37.
- Djaberi, R.; Schuijf, J.D.; Jukema, J.W.; Rabelink, T.J.; Stokkel, M.P.; Smit, J.W.; Koning, E.J. de & Bax, J.J. (2010), Increased Carotid Intima-Media Thickness as a Predictor of the Presence and Extent of Abnormal Myocardial Perfusion in Type 2 Diabetes, Diabetes Care 33(2): 372-374.
- Solingen, C. van; Monge, M.; Vries, D.K. de; Seghers, L.; Vries, M.R. de; Bijkerk, R.; Oeveren-Rietdijk, A.M. van; Veer, E.P. van der; Quax, P.H.A.; Schaapherder, A.F.M.; Boer, H.C. de; Rabelink, A.J. & Zonneveld, A.J. van (2010), SILENCING OF ENDOTHELIAL CELL ENRICHED MICRORNA-126 IS ASSOCIATED WITH ELEVATED SDF-1 LEVELS AND THE INCREASE OF SCA-1+PROGENITOR CELLS AFTER ISCHEMIA REPERFUSION INJURY, Hypertension 56(6): 1167-1167.
- Monge, M.; Zonneveld, A.J. van & Rabelink, T.J. (2010), Circulating cells and dialysis: improving cell number or increasing session number?, Nephrology Dialysis Transplantation 25(12): 3807-3809.
- Mutsaerts, H.J.M.M.; Out, M.; Goedhart, P.T.; Ince, C.; Hardeman, M.R.; Romijn, J.A.; Rabelink, T.J.; Reiber, J.H.C. & Box, F.M.A. (2010), Improved viscosity modeling in patients with type 2 diabetes mellitus by accounting for enhanced red blood cell aggregation tendency, Clinical Hemorheology and Microcirculation 44(4): 302-313.
- Siezenga, M.A.; Geest, R.N. van der; Mallat, M.J.K.; Rabelink, T.J.; Daha, M.R. & Berger, S.P. (2010), Urinary properdin excretion is associated with intrarenal complement activation and poor renal function, Nephrology Dialysis Transplantation 25(4): 1157-1161.
- Rabelink, T.J.; Boer, H.C. de & Zonneveld, A.J. van (2010), Endothelial activation and circulating markers of endothelial activation in kidney disease, Nature Reviews Nephrology 6(7): 404-414.
- Haller, H.; Ito, S.; Izzo, J.L.; Januszewicz, A.; Katayama, S.; Menne, J.; Mimran, A.; Rabelink, T.J.; Ritz, E.; Ruilope, L.M.; Rump, L.C. & Viberti, G. (2010), PREVENTION OF MICROALBUMINURIA: PREDICTORS FOR A GOOD RESPONSE TO OLMESARTAN TREATMENT (ROADMAP TRIAL), Journal of Hypertension 28: E275E275.
- Boer, H.C. de; Hovens, M.M.; Oeveren, A.M. van; Snoep, J.D.; Koning, E.J. de; Tamsma, J.T.; Huisman, M.V.; Rabelink, T.J. & Zonneveld, A.J. van (2010), CD34(+)/KDR+ Cells Are Generated from CD34(+) Cells Under Flow After Immobilization on Activated Platelets and May Serve as a Marker for Vascular Injury, Arteriosclerosis, Thrombosis, and Vascular Biology 30(11): E237E238.
- Steeghs, N.; Rabelink, T.J.; Roodt, J.O. 't; Batman, E.; Cluitmans, F.H.M.; Weijl, N.I.; Koning, E. de & Gelderblom, H. (2010), Reversibility of capillary density after discontinuation of bevacizumab treatment.
- Solingen, C. van; Monge, M.; Vries, D.K. de; Seghers, L.; Vries, M.R. de; Bijkerk, R.; Oeveren-Rietdijk, A.M. van; Veer, E.P. van der; Quax, P.H.; Schaapherder, A.F.; Boer, H.C. de; Rabelink, T.J. & Zonneveld, A.J. van (2010), Silencing of Endothelial Cell-Enriched MicroRNA-126 Is Associated with Elevated SDF-1 and VEGF-A Levels and the Increase of Sca-1(+) Progenitor Cells After Ischemia Reperfusion Injury, Arteriosclerosis, Thrombosis, and Vascular Biology 30(11): E279E279.
- Zaldumbide, A.; Weening, S.; Cramer, S.J.; Rabelink, M.J.W.E.; Verhaagen, J. & Hoeben, R.C. (2010), A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator, Biotechnology Letters 32(6): 749-754.
- Haller, H.; Ritz, E.; Ruilope, L.; Rabelink, T.; Viberti, G. & ROADMAP Steering Comm (2010), Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial), Diabetologia 53: S98S99.
- Haller, H.; Ito, S.; Izzo, J.L.; Januszewicz, A.; Katayama, S.; Menne, J.; Mimran, A.; Rabelink, T.J.; Ritz, E.; Ruilope, L.M.; Rump, L.C. & Viberti, G. (2010), PREVENTION OF MICROALBUMINURIA IN TYPE 2 DIABETES (ROADMAP TRIAL), Journal of Hypertension 28: E233E233.
- Cerezo, C.; Segura, J.; Banegas, J.R.; Cruz, J.J. de la; Garcia-Donaire, J.A.; Rabelink, T.J. & Ruilope, L.M. (2010), TRENDS IN ALBUMINURIA UNDER RENIN-ANGIOTENSIN SYSTEM SUPPRESSION, Journal of Hypertension 28: E446E447.
- Pel, M. van; Monge, M.; Siebelt, M.; Aleksinskaya, M.M.; Boer, H.C. de; Duijs, J.; Solingen, C. van; Massy, Z.; Rabelink, T.J.; Fibbe, W.E. & Zonneveld, A.J. van (2010), Chronic Kidney Disease Induces a Reduction In Hematopoietic Stem -and Progenitor Cell Frequencies, Blood 116(21): 1577-1578.
- Reinders, M.E.J. & Rabelink, T.J. (2010), Adipose tissue-derived stem cells: can impure cell preparations give pure results?, Nephrology Dialysis Transplantation 25(12): 3805-3807.
- Zonneveld, A.J. van; Boer, H.C. de; Veer, E.P. van der & Rabelink, T.J. (2010), Inflammation, vascular injury and repair in rheumatoid arthritis, Annals of the Rheumatic Diseases 69: 57-60.
- Vries, D.K. de; Roest, M.; Lindeman, J.H.N.; Rabelink, T.J.; Groot, P.G. de & Schaapherder, A.F.M. (2010), Endothelial and Thrombocyte Activation Are Not Mediators in Early Ischemia-Reperfusion Injury in Human Kidney Transplantation, American Journal of Transplantation 10: 495-495.
- Steeghs, N.; Rabelink, T.J.; Roodt, J.O. 't; Batman, E.; Cluitmans, F.H.M.; Weijl, N.I.; Koning, E. de & Gelderblom, H. (2010), Reversibility of capillary density after discontinuation of bevacizumab treatment, Annals of Oncology 21(5): 1100-1105.
- Lam, S.; Lodder, K.; Teunisse, A.F.A.S.; Rabelink, M.J.W.E.; Schutte, M. & Jochemsen, A.G. (2010), Role of Mdm4 in drug sensitivity of breast cancer cells, Oncogene 29(16): 2415-2426.
- Reinders, M.E.J.; Fibbe, W.E. & Rabelink, T.J. (2010), Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation, Nephrology Dialysis Transplantation 25(1): 17-24.
- Wijk, J.P.H. van; Hoepelman, I.M.; Koning, E.J.P. de; Dallinga-Thie, G.M.; Rabelink, T.J. & Cabezas, M.C. (2010), Differential Effects of Rosiglitazone and Metformin on Postprandial Remnant-like Particle Cholesterol and Fatty Acid Metabolism in Patients with HIV-Lipodystrophy: A Randomized Study, Atherosclerosis. Supplements 11(1): 71-72.
- Monge, M.; Zonneveld, A.J. van & Rabelink, T.J. (2010), Circulating cells and dialysis: improving cell number or increasing session number?
- Bijkerk, R.; Duijs, J.; Kobayashi, K.; Solingen, C. van; Roeten, M.K.; Veer, E.P. van der; Dijke, P. ten; Boer, H.C. de; Rabelink, T.J.; Goumans, M.J. & Zonneveld, A.J. van (2010), MicroRNA-155 Functions as a Suppressor of Endothelial to Mesenchymal Transition, Arteriosclerosis, Thrombosis, and Vascular Biology 30(11): E236E237.
- Zonneveld, A.J. van; Boer, H.C. de; Veer, E.P. van der & Rabelink, T.J. (2010), Inflammation, vascular injury and repair in rheumatoid arthritis., Annals of the Rheumatic Diseases 69 Suppl 1: i57-60.
- Hoogduijn, M.J.; Popp, F.C.; Grohnert, A.; Crop, M.J.; Rhijn, M. van; Rowshani, A.T.; Eggenhofer, E.; Renner, P.; Reinders, M.E.; Rabelink, T.J.; Laan, L.J.W. van der; Dor, F.J.M.F.; IJzermans, J.N.M.; Genever, P.G.; Lange, C.; Durrbach, A.; Houtgraaf, J.H.; Christ, B.; Seifert, M.; Shagidulin, M.; Donckier, V.; Deans, R.; Ringden, O.; Perico, N.; Remuzzi, G.; Bartholomew, A.; Schlitt, H.J.; Weimar, W.; Baan, C.C.; Dahlke, M.H. & MISOT Study Grp (2010), Advancement of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation (MISOT), Transplantation 90(2): 124-126.
- Januszewicz, A.; Ritz, E.; Viberti, G.; Mimran, A.; Rabelink, A.J.; Rump, L.C.; Ruilope, L.M.; Katayama, S.; Ito, S.; Izzo, J.L. & Haller, H. (2010), Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)., Journal of Human Hypertension.
- Ritz, E.; Viberti, G.C.; Ruilope, L.M.; Rabelink, A.J.; Izzo, J.L.; Katayama, S.; Ito, S.; Mimran, A.; Menne, J.; Rump, L.C.; Januszewicz, A. & Haller, H. (2010), Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study, Diabetologia 53(1): 49-57.
- Engelse MA, Loomans CJ, Oostendorp J, Ringers J, van Rossenberg EH, Steeneveld E, Overdevest JJ, Guchelaar HJ, van Bockel JH, Romijn HA, Fibbe WE, Zwaginga JJ, Rabelink TJ & de Koning EJ (2009), Initiation of a islet isolation program in The Netherlands, Xenotransplantation 16(5): 398-398.
- van Solingen C, Seghers L, Bijkerk R, Duijs JMGJ, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB & de Boer HC (2009), Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis, Journal of Cellular and Molecular Medicine 13(8A): 1577-1585.
- Alipour A, van Oostrom AJ, Van Wijk JP, Verseyden C, Plokker HW, Jukema JW, Rabelink AJ & Castro Cabezas M (2009), Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects.
- Siezenga MA, Shaw PKC, van der Geest RN, Mollnes TE, Daha MR, Rabelink TJ & Berger SP (2009), Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians, Clinical and Experimental Immunology 157(1): 98-103.
- Mooyaart AL, van Valkengoed IGM, Shaw PKC, Peters V, Baelde HJ, Rabelink TJ, Bruijn JA, Stronks K & de Heer E (2009), Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese, Diabetes Research and Clinical Practice 85(3): 272-278.
- de Bie MK, van Dam B, Gaasbeek A, van Buren M, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ & Jukema JW (2009), The current status of interventions aiming at reducing sudden cardiac death in dialysis patients., European Heart Journal 30(13): 1559-64.
- Wang XL, Herr RA, Rabelink M, Hoeben RC, Wiertz EJHJ & Hansen TH (2009), Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates, Journal of Cell Biology 187(5): 655-668.
- Verloop RE, Koolwijk P, van Zonneveld AJ & van Hinsbergh VWM (2009), Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization, European Cytokine Network 20(4): 207-219.
- de Vries DK, Roest M, Lindeman JHN, Ringers J, Rabelink TJ, de Groot PG & Schaapherder AFM (2009), ENDOTHELIAL AND THROMBOCYTE ACTIVATION ARE NO INITIATORS OF EARLY ISCHEMIA-REPERFUSION INJURY IN HUMAN KIDNEY TRANSPLANTATION, Transplant International 22: 274-274.
- Rabelink TJ & Rotmans JI (2009), Salt is getting under our skin, Nephrology Dialysis Transplantation 24(11): 3282-3283.
- de Bie MK, van Dam B, Gaasbeek A, van Buren M, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ & Jukema JW (2009), The current status of interventions aiming at reducing sudden cardiac death in dialysis patients, European Heart Journal 30(13): 1559-1564.
- Djaberi, R.; Schuijf, J.D.; Koning, E.J. de; Rabelink, T.J.; Smit, J.W.; Kroft, L.J.M.; Pereira, A.M.; Scholte, A.J.; Spaans, M.; Romijn, J.A.; Roos, A. de; Wall, E.E. van der; Jukema, J.W. & Bax, J.J. (2009), Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery disease., American Journal of Cardiology 104(8): 1041-6.
- Steeghs N, Rabelink TJ, op 't Roodt J, de Koning E & Gelderblom H (2009), Bevacizumab-related hypertension: Search for underlying mechanisms, Journal of Clinical Oncology 27(15).
- Uil TG, de Vrij J, Vellinga J, Rabelink MJWE, Cramer SJ, Chan OYA, Pugnali M, Magnusson M, Lindholm L & Boulanger P (2009), A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers, Journal of Gene Medicine 11(11): 990-1004.
- Ritz E, Viberti G, Mimran A, Rabelink A, Januszewicz A, Rump L, Ruilope L, Katayama S, Ito S & Izzo J (2009), DETERMINANTS OF ALBUMIN EXCRETION IN NORMOALBUMINURIC PATIENTS WITH TYPE 2 DIABETES (ROADMAP STUDY), Journal of Hypertension 27: S336S336.
- Djaberi R, op 't Roodt J, Schuijf JD, Rabelink TJ, de Koning EJ, Pereira AM, Stokkel MP, Smit JW, Bax JJ & Jukema JW (2009), Endothelial Dysfunction in Diabetic Patients with Abnormal Myocardial Perfusion in the Absence of Epicardial Obstructive Coronary Artery Disease, Journal of Nuclear Medicine 50(12): 1980-1986.
- Djaberi, R.; Roodt, J. op 't; Schuijf, J.D.; Rabelink, T.J.; Koning, E.J. de; Pereira, A.M.; Stokkel, M.P.; Smit, J.W.; Bax, J.J. & Jukema, J.W. (2009), Endothelial dysfunction in diabetic patients with abnormal myocardial perfusion in the absence of epicardial obstructive coronary artery disease.
- Rabelink TJ & Rotmans JI (2009), Salt is getting under our skin.
- de Vries DK, Lindeman JHN, Ringers J, Rabelink TJ & Schaapherder AFM (2009), BRAIN DEATH PREDISPOSES THE KIDNEY TO A PRO-INFLAMMATORY RESPONSE UPON REPERFUSION, Transplant International 22: 44-44.
- Bax L, Woittiez AJJ, Kouwenberg HJ, Mali WPTM, Buskens E, Beek FJA, Braam B, Huysmans FTM, Kool LJS & Rutten MJCM (2009), Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function A Randomized Trial, Annals of Internal Medicine 150(12): 840U41.
- Djaberi R, Schuijf JD, de Koning EJ, Rabelink TJ, Smit JW, Kroft LJM, Pereira AM, Scholte AJ, Spaans M, Romijn JA, de Roos A, van der Wall EE, Jukema JW & Bax JJ (2009), Usefulness of Carotid Intima-Media Thickness in Patients With Diabetes Mellitus as a Predictor of Coronary Artery Disease, American Journal of Cardiology 104(8): 1041-1046.
- Loomans CJ, van Haperen R, Duijs JM, Verseyden C, de Crom R, Leenen PJ, Drexhage HA, de Boer HC, de Koning EJ, Rabelink TJ, Staal FJ & van Zonneveld AJ (2009), Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia.
- Izzo JL, Pecen L, Ito S, Januszewicz A, Katayama S, Mimran A, Rabelink T, Ritz E, Ruilope L & Rump L (2009), INFLUENCE OF JNC 7 BLOOD PRESSURE (BP) STAGE ON ANTIHYPERTENSIVE DRUG BENEFITS IN DIABETICS: THE ROADMAP EXPERIENCE AT ONE YEAR, Journal of Hypertension 27: S271S272.
- Djaberi R, Schuijf JD, de Koning EJ, Rabelink TJ, Spaans M, Pereira AM, Smit JW, Bax JJ & Jukema JW (2009), Use of Carotid Intima Media Thickness for Identification of Patients With Diabetes Mellitus at High Risk for Coronary Artery Disease, Journal of the American College of Cardiology 53(10): A436A436.
- Mourer JS, de Koning EJP, Berger SP, Roodt JO, Spaans M, Rabelink AJ & de Fijter JW (2008), Effects of CNI or MMF withdrawal on carotid intima media thickness in renal transplant recipients, American Journal of Transplantation 8.
- Goumans MJ, van Zonneveld AJ & ten Dijke P (2008), Transforming Growth Factor beta-Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis?, Trends in Cardiovascular Medicine 18(8): 293-298.
- Haller H, Januszewicz A, Ito S, Izzo JL, Katayama S, Mimran A, Rabelink AJ, Ritz E, Ruilope LM, Rump LC & Viberti GC (2008), Cardiovascular risk is associated with night-time rather than daytime blood pressure in normoalbuminuric type 2 diabetic patients, Diabetologia 51.
- Januszewicz A, Ito S, Izzo JL, Katayama S, Mimran A, Rabelink AJ, Ritz E, Ruilope LM, Rump LC, Viberti G & Haller H (2008), Relation of pulse pressure and ambulatory arterial stiffness index with clinical characteristics and cardiovascular risk factors in type 2 diabetic patients, Diabetologia 51.
- Alipour A, Van Oostrom AJ, Van Wijk JP, Verseyden C, Plokker HW, Jukema JW, Rabelink AJ & Cabezas MC (2007), Deficiency of mannose binding lectin is associated with increased postprandial VLDL1 despite normal fasting plasma triglycerides, Circulation 116(16).
- Rump LC, Ambrosioni E, Burnier M, Horl W & Rabelink AJ (2006), Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension, Journal of Human Hypertension 20(4).
- Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL & Januszewicz A (2006), Preventing microalbuminuria in patients with diabetes: rationale and design of the Randornised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study, Journal of Hypertension 24(2).
- Chief Scientific Officer